<html class="gs_el_sm gs_pfcs"><head><title>‪Anna Maria Geretti‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.co.uk/citations?user=knKf83IAAAAJ&amp;hl=en"><meta name="description" content="‪University of Liverpool‬ - ‪‪Cited by 13,404‬‬ - ‪Virology‬"><meta property="og:description" content="‪University of Liverpool‬ - ‪‪Cited by 13,404‬‬ - ‪Virology‬"><meta property="og:title" content="Anna Maria Geretti"><meta property="og:image" content="https://scholar.google.com/citations/images/avatar_scholar_256.png"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"RhdCYbChBsLMsQKvlwo"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=knKf83IAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=knKf83IAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=knKf83IAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=knKf83IAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYUNoxpkGrUYmWavB8ccd1jBK2W-JDqpY"><input type="hidden" name="user" value="knKf83IAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">13404</td><td class="gsc_rsb_std">7004</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">60</td><td class="gsc_rsb_std">42</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">186</td><td class="gsc_rsb_std">126</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:870px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:824px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">1400</div><div class="gsc_g_xtl" style="top:73px;">700</div><div class="gsc_g_xtl" style="top:113px;">350</div><div class="gsc_g_xtl" style="top:33px;">1050</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:157px;height:3px;z-index:25"><span class="gsc_g_al">34</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:156px;height:4px;z-index:24"><span class="gsc_g_al">36</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:153px;height:7px;z-index:23"><span class="gsc_g_al">66</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:155px;height:5px;z-index:22"><span class="gsc_g_al">44</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:154px;height:6px;z-index:21"><span class="gsc_g_al">59</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:153px;height:7px;z-index:20"><span class="gsc_g_al">64</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:155px;height:5px;z-index:19"><span class="gsc_g_al">50</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:154px;height:6px;z-index:18"><span class="gsc_g_al">55</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:152px;height:8px;z-index:17"><span class="gsc_g_al">78</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:145px;height:15px;z-index:16"><span class="gsc_g_al">138</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:131px;height:29px;z-index:15"><span class="gsc_g_al">255</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:119px;height:41px;z-index:14"><span class="gsc_g_al">366</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:112px;height:48px;z-index:13"><span class="gsc_g_al">426</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:102px;height:58px;z-index:12"><span class="gsc_g_al">515</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:89px;height:71px;z-index:11"><span class="gsc_g_al">625</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:79px;height:81px;z-index:10"><span class="gsc_g_al">711</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:67px;height:93px;z-index:9"><span class="gsc_g_al">821</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:52px;height:108px;z-index:8"><span class="gsc_g_al">950</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:59px;height:101px;z-index:7"><span class="gsc_g_al">884</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:32px;height:128px;z-index:6"><span class="gsc_g_al">1120</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:33px;height:127px;z-index:5"><span class="gsc_g_al">1118</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:35px;height:125px;z-index:4"><span class="gsc_g_al">1095</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:24px;height:136px;z-index:3"><span class="gsc_g_al">1198</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:6px;height:154px;z-index:2"><span class="gsc_g_al">1353</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:42px;height:118px;z-index:1"><span class="gsc_g_al">1038</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=knKf83IAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dknKf83IAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>64 articles</span></div><div class="gsc_rsb_m_na"><div>1 article</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:2%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:128px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:80pt;height:80pt;}}</style><img alt="Anna Maria Geretti" sizes="print 80px,128px" src="/citations/images/avatar_scholar_128.png" id="gsc_prf_pup-img" srcset="/citations/images/avatar_scholar_128.png 128w,/citations/images/avatar_scholar_256.png 256w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Anna Maria Geretti</div><div class="gsc_prf_il"><a href="/citations?view_op=view_org&amp;hl=en&amp;org=14990939326409045635" class="gsc_prf_ila">University of Liverpool</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at liverpool.ac.uk</div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:virology" class="gsc_prf_inta gs_ibl">Virology</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=knKf83IAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYUNoxpkGrUYmWavB8ccd1jBK2W-JDqpY"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=knKf83IAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=knKf83IAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=knKf83IAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=knKf83IAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=knKf83IAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:DUooU5lO8OsC" class="gsc_a_at">Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy</a><div class="gs_gray">AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, J Van Lunzen, ...</div><div class="gs_gray">Jama 316 (2), 171-181<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2518651480059304613" class="gsc_a_ac gs_ibl">1150</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:UuEBAcK4md4C" class="gsc_a_at">British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008</a><div class="gs_gray">BG Gazzard, J Anderson, A Babiker, M Boffito, G Brook, G Brough, ...</div><div class="gs_gray">HIV medicine 9 (8), 563-608<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9324770587654680041" class="gsc_a_ac gs_ibl">447</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:HhcuHIWmDEUC" class="gsc_a_at">Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of&nbsp;…</a><div class="gs_gray">AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ...</div><div class="gs_gray">The Lancet 393 (10189), 2428-2438<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11178757965543923933" class="gsc_a_ac gs_ibl">439</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012</a><div class="gs_gray">I Williams, D Churchill, J Anderson, M Boffito, M Bower, G Cairns, ...</div><div class="gs_gray">HIV medicine 13 (S2), 1-6<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10055963537817576786,946937288016608385,358247385294501347,7850032169334277738" class="gsc_a_ac gs_ibl">390</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis</a><div class="gs_gray">JZ Li, R Paredes, HJ Ribaudo, ES Svarovskaia, KJ Metzner, MJ Kozal, ...</div><div class="gs_gray">Jama 305 (13), 1327-1335<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14683806283096610845" class="gsc_a_ac gs_ibl">370</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER study</a><div class="gs_gray">A Rodger, T Bruun, V Cambiano, P Vernazza, V Estrada, J Van Lunzen, ...</div><div class="gs_gray">Conference on Retroviruses and Opportunistic Infections, 3-6<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1109603886549127501" class="gsc_a_ac gs_ibl">325</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">Role of the coinhibitory receptor cytotoxic T lymphocyte antigen‐4 on apoptosis‐Prone CD8 T cells in persistent hepatitis B virus infection</a><div class="gs_gray">A Schurich, P Khanna, AR Lopes, KJ Han, D Peppa, L Micco, G Nebbia, ...</div><div class="gs_gray">Hepatology 53 (5), 1494-1503<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17591597910135643138" class="gsc_a_ac gs_ibl">289</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">European guidelines on the clinical management of HIV-1 tropism testing</a><div class="gs_gray">LPR Vandekerckhove, AMJ Wensing, R Kaiser, F Brun-Vézinet, B Clotet, ...</div><div class="gs_gray">The Lancet infectious diseases 11 (5), 394-407<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=504919854273419668" class="gsc_a_ac gs_ibl">289</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">HIV-1 subtypes: epidemiology and significance for HIV management</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Current opinion in infectious diseases 19 (1), 1-7<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8344082578324639316" class="gsc_a_ac gs_ibl">278</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:qjMakFHDy7sC" class="gsc_a_at">Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America</a><div class="gs_gray">Antiretroviral Therapy Cohort Collaboration</div><div class="gs_gray">Clinical Infectious Diseases 41 (12), 1772-1782<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8092557854074530953" class="gsc_a_ac gs_ibl">261</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:lSLTfruPkqcC" class="gsc_a_at">Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study</a><div class="gs_gray">M Daskalopoulou, A Rodger, AN Phillips, L Sherr, A Speakman, S Collins, ...</div><div class="gs_gray">The lancet HIV 1 (1), e22-e31<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7458814173434786078" class="gsc_a_ac gs_ibl">256</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:k_7cPK9k7w8C" class="gsc_a_at">British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)</a><div class="gs_gray">B Gazzard, AJ Bernard, M Boffito, D Churchill, S Edwards, N Fisher, ...</div><div class="gs_gray">HIV medicine 7 (8), 487-503<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17352652271329963158" class="gsc_a_ac gs_ibl">252</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Human immunodeficiency virus type 1 Rev-and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.</a><div class="gs_gray">CA van Baalen, O Pontesilli, RC Huisman, AM Geretti, MR Klein, ...</div><div class="gs_gray">Journal of General Virology 78 (8), 1913-1918<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7181020015749365376" class="gsc_a_ac gs_ibl">246</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011</a><div class="gs_gray">D Asboe, C Aitken, M Boffito, C Booth, P Cane, A Fakoya, AM Geretti, ...</div><div class="gs_gray">HIV med 13 (1), 1-44<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8491647607298485144" class="gsc_a_ac gs_ibl">218</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:nZcligLrVowC" class="gsc_a_at">Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study</a><div class="gs_gray">UK Group on Transmitted HIV Drug Resistance</div><div class="gs_gray">Bmj 331 (7529), 1368<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14559355025752504539" class="gsc_a_ac gs_ibl">213</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Herpes simplex virus type 2: epidemiology and management options in developing countries</a><div class="gs_gray">G Paz-Bailey, M Ramaswamy, SJ Hawkes, AM Geretti</div><div class="gs_gray">Sexually transmitted infections 83 (1), 16-22<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17681644966038321622" class="gsc_a_ac gs_ibl">202</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy</a><div class="gs_gray">AM Geretti, L Harrison, H Green, C Sabin, T Hill, E Fearnhill, D Pillay, ...</div><div class="gs_gray">Clinical infectious diseases 48 (9), 1296-1305<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3336590589189998049" class="gsc_a_ac gs_ibl">177</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:WF5omc3nYNoC" class="gsc_a_at">Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy</a><div class="gs_gray">T Doyle, C Smith, P Vitiello, V Cambiano, M Johnson, A Owen, AN Phillips, ...</div><div class="gs_gray">Clinical Infectious Diseases 54 (5), 724-732<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=339049503371164159" class="gsc_a_ac gs_ibl">173</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa</a><div class="gs_gray">PC Matthews, AM Geretti, PJR Goulder, P Klenerman</div><div class="gs_gray">Journal of clinical virology 61 (1), 20-33<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12673653592372513928" class="gsc_a_ac gs_ibl">171</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;citation_for_view=knKf83IAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy</a><div class="gs_gray">PJ Easterbrook, M Smith, J Mullen, S O'Shea, I Chrystie, A de Ruiter, ...</div><div class="gs_gray">Journal of the International AIDS Society 13 (1), 1-9<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5006510284459811672" class="gsc_a_ac gs_ibl">166</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">European guideline for the management of genital herpes, 2010</a><div class="gs_gray">R Patel, S Alderson, A Geretti, A Nilsen, E Foley, S Lautenschlager, ...</div><div class="gs_gray">International journal of STD &amp; AIDS 22 (1), 1-10<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14314803989002050974" class="gsc_a_ac gs_ibl">144</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection</a><div class="gs_gray">CL Booth, AM Geretti</div><div class="gs_gray">Journal of antimicrobial chemotherapy 59 (6), 1047-1056<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4203550484526846191" class="gsc_a_ac gs_ibl">142</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Epidemiology of antiretroviral drug resistance in drug-naive persons</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Current opinion in infectious diseases 20 (1), 22-32<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8883962397900815688" class="gsc_a_ac gs_ibl">127</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454&nbsp;…</a><div class="gs_gray">A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ...</div><div class="gs_gray">Journal of antimicrobial chemotherapy 70 (3), 930-940<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18383868335512524431" class="gsc_a_ac gs_ibl">117</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">British HIV Association guidelines for immunization of HIV‐infected adults 2008</a><div class="gs_gray">AM Geretti, BHIVA Immunization Writing Committee</div><div class="gs_gray">HIV medicine 9 (10), 795-848<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12567966274425647354" class="gsc_a_ac gs_ibl">114</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection</a><div class="gs_gray">CL Booth, AM Garcia-Diaz, MS Youle, MA Johnson, A Phillips, AM Geretti</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 59 (3), 517-524<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13516867089715613645" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana</a><div class="gs_gray">AM Geretti, M Patel, FS Sarfo, D Chadwick, J Verheyen, M Fraune, ...</div><div class="gs_gray">Journal of clinical microbiology 48 (9), 3223-3230<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13516426454214290975" class="gsc_a_ac gs_ibl">108</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:ufrVoPGSRksC" class="gsc_a_at">A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients</a><div class="gs_gray">FM Mattes, EG Hainsworth, AM Geretti, G Nebbia, G Prentice, M Potter, ...</div><div class="gs_gray">The Journal of infectious diseases 189 (8), 1355-1361<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10835368283532243143" class="gsc_a_ac gs_ibl">108</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Persistence of HIV-1 transmitted drug resistance mutations</a><div class="gs_gray">H Castro, D Pillay, P Cane, D Asboe, V Cambiano, A Phillips, DT Dunn, ...</div><div class="gs_gray">The Journal of infectious diseases 208 (9), 1459-1463<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=397463881230942477" class="gsc_a_ac gs_ibl">105</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:LgRImbQfgY4C" class="gsc_a_at">Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR-and XDR-TB</a><div class="gs_gray">S Tiberi, MC Payen, G Sotgiu, L D'Ambrosio, VA Guizado, JW Alffenaar, ...</div><div class="gs_gray">European Respiratory Journal 47 (4), 1235-1243<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11135269587981917718" class="gsc_a_ac gs_ibl">104</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:Se3iqnhoufwC" class="gsc_a_at">Diagnosis of genital herpes by real time PCR in routine clinical practice</a><div class="gs_gray">M Ramaswamy, C McDonald, M Smith, D Thomas, S Maxwell, ...</div><div class="gs_gray">Sexually transmitted infections 80 (5), 406-410<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6415147480007756361" class="gsc_a_ac gs_ibl">103</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:5nxA0vEk-isC" class="gsc_a_at">Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy</a><div class="gs_gray">AM Geretti, C Smith, A Haberl, A Garcia-Diaz, G Nebbia, M Johnson, ...</div><div class="gs_gray">Antivir Ther 13 (7), 927-36<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4916493113287469153" class="gsc_a_ac gs_ibl">101</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1&nbsp;…</a><div class="gs_gray">A Chawla, G Murphy, C Donnelly, CL Booth, M Johnson, JV Parry, ...</div><div class="gs_gray">Journal of clinical microbiology 45 (2), 415-420<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8648391704274183507" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:6bLC7aUMtPcC" class="gsc_a_at">Risk of HIV transmission through condomless sex in MSM couples with suppressive ART: The PARTNER2 Study extended results in gay men</a><div class="gs_gray">A Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, GM Corbelli, ...</div><div class="gs_gray">Journal of the International AIDS Society 21 (Supplement 6), 163-163<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15881199197053038717" class="gsc_a_ac gs_ibl">94</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">HIV forensics: pitfalls and acceptable standards in the use of phylogenetic analysis as evidence in criminal investigations of HIV transmission<sup>*</sup></a><div class="gs_gray">EJ Bernard, Y Azad, AM Vandamme, M Weait, AM Geretti</div><div class="gs_gray">HIV medicine 8 (6), 382-387<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9653061201516238924" class="gsc_a_ac gs_ibl">94</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:u_35RYKgDlwC" class="gsc_a_at">2014 European guideline on HIV testing</a><div class="gs_gray">D Gökengin, AM Geretti, J Begovac, A Palfreeman, M Stevanovic, ...</div><div class="gs_gray">International journal of STD &amp; AIDS 25 (10), 695-704<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8709352391480209123,4006240359739303030" class="gsc_a_ac gs_ibl">92</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Emerging patterns and implications of HIV-1 integrase inhibitor resistance</a><div class="gs_gray">AM Geretti, D Armenia, F Ceccherini-Silberstein</div><div class="gs_gray">Current opinion in infectious diseases 25 (6), 677-686<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8773982438627594596" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR-and XDR-TB</a><div class="gs_gray">S Tiberi, G Sotgiu, L D'Ambrosio, R Centis, MA Arbex, EA Arrascue, ...</div><div class="gs_gray">European Respiratory Journal 47 (6), 1758-1766<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=48721328451699249" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">Low-level viraemia on HAART: significance and management</a><div class="gs_gray">T Doyle, AM Geretti</div><div class="gs_gray">Current opinion in infectious diseases 25 (1), 17-25<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10013446285932474711" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades</a><div class="gs_gray">T Doyle, DT Dunn, F Ceccherini-Silberstein, C De Mendoza, F Garcia, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 70 (11), 3080-3086<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1616920341368123347" class="gsc_a_ac gs_ibl">79</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:zGdJYJv2LkUC" class="gsc_a_at">The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis</a><div class="gs_gray">AJ Stockdale, B Kreuels, MYR Henrion, E Giorgi, I Kyomuhangi, ...</div><div class="gs_gray">Journal of hepatology 73 (3), 523-532<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4244470182730135585" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Prevalence and characteristics of hepatitis B virus (HBV) coinfection among HIV-Positive women in South Africa and Botswana</a><div class="gs_gray">PC Matthews, A Beloukas, A Malik, JM Carlson, P Jooste, A Ogwu, ...</div><div class="gs_gray">PLoS One 10 (7), e0134037<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10582760672710652381" class="gsc_a_ac gs_ibl">75</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Long-term trends in adherence to antiretroviral therapy from start of HAART</a><div class="gs_gray">V Cambiano, FC Lampe, AJ Rodger, CJ Smith, AM Geretti, RK Lodwick, ...</div><div class="gs_gray">Aids 24 (8), 1153-1162<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3560017001285120951" class="gsc_a_ac gs_ibl">75</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:OTTXONDVkokC" class="gsc_a_at">Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses</a><div class="gs_gray">LS Burch, CJ Smith, J Anderson, L Sherr, AJ Rodger, R O'Connell, ...</div><div class="gs_gray">The Lancet Public Health 1 (1), e26-e36<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6142699716469547476" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:jL-93Qbq4QoC" class="gsc_a_at">Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis</a><div class="gs_gray">AJ Stockdale, M Chaponda, A Beloukas, RO Phillips, PC Matthews, ...</div><div class="gs_gray">The Lancet global health 5 (10), e992-e1003<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12671359966517887538" class="gsc_a_ac gs_ibl">73</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013</a><div class="gs_gray">E Wilkins, M Nelson, K Agarwal, D Awoyemi, E Barnes, S Bhagani, ...</div><div class="gs_gray">HIV medicine 14, 1-71<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9665358740896345993" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy</a><div class="gs_gray">AM Geretti, ZV Fox, CL Booth, CJ Smith, AN Phillips, M Johnson, JF Li, ...</div><div class="gs_gray">JAIDS Journal of Acquired Immune Deficiency Syndromes 52 (5), 569-573<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1188288911284640923" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:roLk4NBRz8UC" class="gsc_a_at">HHV‐6‐related secondary graft failure following allogeneic bone marrow transplantation</a><div class="gs_gray">RE Johnston, AM Geretti, HG Prentice, AD Clark, AC Wheeler, M Potter, ...</div><div class="gs_gray">British journal of haematology 105 (4), 1041-1043<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6263439117644991717" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Global HIV‐1 transmitted drug resistance in the INSIGHT S trategic T iming of A nti R etroviral T reatment (START) trial</a><div class="gs_gray">JD Baxter, D Dunn, E White, S Sharma, AM Geretti, MJ Kozal, ...</div><div class="gs_gray">HIV medicine 16, 77-87<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7427888123400964626" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:NhqRSupF_l8C" class="gsc_a_at">Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaboration</a><div class="gs_gray">LC Swenson, B Cobb, AM Geretti, PR Harrigan, M Poljak, ...</div><div class="gs_gray">Journal of clinical microbiology 52 (2), 517-523<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9848383698982418615" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:8k81kl-MbHgC" class="gsc_a_at">Concordance between HIV‐1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA</a><div class="gs_gray">C Verhofstede, D Brudney, J Reynaerts, D Vaira, K Fransen, A De Bel, ...</div><div class="gs_gray">HIV medicine 12 (9), 544-552<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12002193291668546900" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:0EnyYjriUFMC" class="gsc_a_at">Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection</a><div class="gs_gray">C Garrido, AM Geretti, N Zahonero, C Booth, A Strang, V Soriano, ...</div><div class="gs_gray">Journal of antimicrobial chemotherapy 65 (2), 320-326<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1802562500165244751" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:UebtZRa9Y70C" class="gsc_a_at">Towards and HIV-1 vaccine: lessons from studies in macaque models</a><div class="gs_gray">EGJ Hulskotte, AM Geretti, ADME Osterhaus</div><div class="gs_gray">Vaccine 16 (9-10), 904-915<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9063258820199390082" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:3NQIlFlcGxIC" class="gsc_a_at">Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study</a><div class="gs_gray">F McGill, MJ Griffiths, LJ Bonnett, AM Geretti, BD Michael, NJ Beeching, ...</div><div class="gs_gray">The Lancet infectious diseases 18 (9), 992-1003<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7252176623356960504" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients–impact of HIV subtypes and prior raltegravir experience</a><div class="gs_gray">C Garrido, V Soriano, AM Geretti, N Zahonero, S Garcia, C Booth, ...</div><div class="gs_gray">Antiviral research 90 (3), 164-167<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12709873444889804445" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Evidence for onward transmission of HIV-1 non-B subtype strains in the United Kingdom</a><div class="gs_gray">I Aggarwal, M Smith, ID Tatt, S Murad, N Osner, AM Geretti, ...</div><div class="gs_gray">JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (2), 201-209<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15520030344581759932" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom</a><div class="gs_gray">A Tostevin, E White, D Dunn, S Croxford, V Delpech, I Williams, D Asboe, ...</div><div class="gs_gray">HIV medicine 18 (3), 204-213<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11705630162755253373" class="gsc_a_ac gs_ibl">62</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:CYCckWUYoCcC" class="gsc_a_at">Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study</a><div class="gs_gray">AM Geretti, AJ Stockdale, SH Kelly, M Cevik, S Collins, L Waters, G Villa, ...</div><div class="gs_gray">Clinical Infectious Diseases<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17678797019694362166" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:EYYDruWGBe4C" class="gsc_a_at">2017 European guidelines for the management of genital herpes</a><div class="gs_gray">R Patel, OJ Kennedy, E Clarke, A Geretti, A Nilsen, S Lautenschlager, ...</div><div class="gs_gray">International journal of STD &amp; AIDS 28 (14), 1366-1379<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16934262237165863125" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:HDshCWvjkbEC" class="gsc_a_at">Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure</a><div class="gs_gray">JZ Li, R Paredes, HJ Ribaudo, MJ Kozal, ES Svarovskaia, JA Johnson, ...</div><div class="gs_gray">The Journal of infectious diseases 207 (6), 893-897<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2703364999938964314" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors</a><div class="gs_gray">C Cellerai, A Harari, H Stauss, S Yerly, AM Geretti, A Carroll, T Yee, ...</div><div class="gs_gray">PloS one 6 (4), e18164<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7493423222806238363" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5)</a><div class="gs_gray">EG Hulskotte, AM Geretti, KH Siebelink, G van Amerongen, MP Cranage, ...</div><div class="gs_gray">Journal of Virology 69 (10), 6289-6296<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15203855566917431675" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:hC7cP41nSMkC" class="gsc_a_at">Comparative evaluation of the ExaVir Load version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load</a><div class="gs_gray">W Labbett, A Garcia-Diaz, Z Fox, GS Clewley, T Fernandez, M Johnson, ...</div><div class="gs_gray">Journal of clinical microbiology 47 (10), 3266-3270<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3283687542181720671" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.</a><div class="gs_gray">C van Baalen, M Klein, AM Geretti, RIPM Keet, F Miedema, C van Els, ...</div><div class="gs_gray">Aids 7, 781-786<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14335955774251882917,3039545797007071813" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">Effectiveness and safety of imipenem-clavulanate added to an optimized background regimen (OBR) versus OBR control regimens in the treatment of multidrug-resistant and&nbsp;…</a><div class="gs_gray">S Tiberi, G Sotgiu, L D'Ambrosio, R Centis, MA Arbex, E Alarcon Arrascue, ...</div><div class="gs_gray">Clinical Infectious Diseases 62 (9), 1188-1190<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17698741309339879574,16673193736734438751" class="gsc_a_ac gs_ibl">55</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="knKf83IAAAAJ:vDZJ-YLwNdEC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:4DMP91E08xMC" class="gsc_a_at">Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia</a><div class="gs_gray">NE Mackie, AN Phillips, S Kaye, C Booth, AM Geretti</div><div class="gs_gray">The Journal of infectious diseases 201 (9), 1303-1307<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2650729121108541184" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">Predictors and kinetics of occult hepatitis B virus infection in HIV‐infected persons</a><div class="gs_gray">G Nebbia, A Garcia‐Diaz, U Ayliffe, C Smith, S Dervisevic, M Johnson, ...</div><div class="gs_gray">Journal of medical virology 79 (10), 1464-1471<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17413441447159743635" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA</a><div class="gs_gray">M Schutten, D Peters, NKT Back, M Beld, K Beuselinck, V Foulongne, ...</div><div class="gs_gray">Journal of clinical microbiology 45 (6), 1712-1717<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11557457099907900335" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:TQgYirikUcIC" class="gsc_a_at">Immunization for HIV-positive individuals</a><div class="gs_gray">AM Geretti, T Doyle</div><div class="gs_gray">Current opinion in infectious diseases 23 (1), 32-38<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10948930277753429334" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Liver fibrosis by transient elastography and virologic outcomes after introduction of tenofovir in lamivudine-experienced adults with HIV and hepatitis B virus coinfection in Ghana</a><div class="gs_gray">AJ Stockdale, RO Phillips, A Beloukas, LT Appiah, D Chadwick, ...</div><div class="gs_gray">Clinical Infectious Diseases 61 (6), 883-891<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10048357831328009288" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:kJDgFkosVoMC" class="gsc_a_at">Clinical implications of HIV drug resistance to nucleoside and nucleotide reverse transcriptase inhibitors.</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">AIDS reviews 8 (4), 210-220<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1032982003938134039" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">British HIV association guidelines on the use of vaccines in HIV-positive adults 2015</a><div class="gs_gray">AM Geretti, G Brook, C Cameron, D Chadwick, N French, R Heyderman, ...</div><div class="gs_gray">HIV medicine 17 (53), S2-S81<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8827458510241513841" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">Comparative performance of the new Aptima HIV-1 Quant Dx assay with three commercial PCR-based HIV-1 RNA quantitation assays</a><div class="gs_gray">M Hopkins, S Hau, C Tiernan, A Papadimitropoulos, A Chawla, ...</div><div class="gs_gray">Journal of Clinical Virology 69, 56-62<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14945239845715518415" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:_OXeSy2IsFwC" class="gsc_a_at">IAPAC guidelines for optimizing the HIV care continuum for adults and adolescents</a><div class="gs_gray">International Advisory Panel on HIV Care Continuum Optimization</div><div class="gs_gray">Journal of the International Association of Providers of AIDS Care (JIAPAC&nbsp;…<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4790020762399568255" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:prdVHNxh-e8C" class="gsc_a_at">Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study</a><div class="gs_gray">UK CHIC Study Steering Committee, TJ Barber, AM Geretti, J Anderson, ...</div><div class="gs_gray">Antiviral therapy 16 (6), 805-814<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7277714031786366105" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">The impact of transmitted drug-resistance on treatment selection and outcome of first-line highly active antiretroviral therapy (HAART)</a><div class="gs_gray">L Bansi, AM Geretti, D Dunn, T Hill, H Green, E Fearnhill, B Gazzard, ...</div><div class="gs_gray">JAIDS Journal of Acquired Immune Deficiency Syndromes 53 (5), 633-639<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10078930812325031639" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:4TOpqqG69KYC" class="gsc_a_at">When and how to use maraviroc in HIV-infected patients</a><div class="gs_gray">V Soriano, CF Perno, R Kaiser, V Calvez, JM Gatell, G Di Perri, D Pillay, ...</div><div class="gs_gray">Aids 23 (18), 2377-2385<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7430106074667636000" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">Genital herpes</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Sexually transmitted infections 82 (suppl 4), iv31-iv34<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15246093653367025073" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following&nbsp;…</a><div class="gs_gray">A Garcia-Diaz, GS Clewley, CL Booth, W Labett, N McAllister, AM Geretti</div><div class="gs_gray">Journal of clinical microbiology 44 (5), 1788-1791<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5038968053014648722" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Dynamics of cellular HIV-1 DNA levels over 144 weeks of darunavir/ritonavir monotherapy versus triple therapy in the MONET trial</a><div class="gs_gray">AM Geretti, JR Arribas, E Lathouwers, GM Foster, R Yakoob, S Kinloch, ...</div><div class="gs_gray">HIV clinical trials 14 (1), 45-50<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9733230737110177933" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action</a><div class="gs_gray">J Mokaya, AL McNaughton, MJ Hadley, A Beloukas, AM Geretti, ...</div><div class="gs_gray">PLoS neglected tropical diseases 12 (8), e0006629<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8719560536724074564" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:FiytvqdAVhgC" class="gsc_a_at">Age, time living with diagnosed HIV infection, and self‐rated health</a><div class="gs_gray">JA McGowan, L Sherr, AJ Rodger, M Fisher, A Miners, J Anderson, ...</div><div class="gs_gray">HIV medicine 18 (2), 89-103<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9166706076146569949" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:0izLItjtcgwC" class="gsc_a_at">Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia</a><div class="gs_gray">S Nightingale, AM Geretti, A Beloukas, M Fisher, A Winston, L Else, ...</div><div class="gs_gray">Journal of neurovirology 22 (6), 852-860<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1305542583299518479" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults</a><div class="gs_gray">J Molton, C Smith, S Chaytor, P Maple, K Brown, M Johnson, AM Geretti</div><div class="gs_gray">Journal of Infection 61 (1), 73-80<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14794794136178778875" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:IWHjjKOFINEC" class="gsc_a_at">HIV phylogenetics</a><div class="gs_gray">D Pillay, A Rambaut, AM Geretti, AJL Brown</div><div class="gs_gray">Bmj 335 (7618), 460-461<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1570895437121059980" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:qUcmZB5y_30C" class="gsc_a_at">The effect of transmitted HIV-1 drug resistance on pre-therapy viral load</a><div class="gs_gray">L Harrison, H Castro, P Cane, D Pillay, C Booth, A Phillips, AM Geretti, ...</div><div class="gs_gray">Aids 24 (12), 1917-1922<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=667911833680254853" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:hMod-77fHWUC" class="gsc_a_at">Ongoing changes in HIV RNA levels during untreated HIV infection: implications for CD4 cell count depletion</a><div class="gs_gray">AN Phillips, FC Lampe, CJ Smith, AM Geretti, A Rodger, RK Lodwick, ...</div><div class="gs_gray">Aids 24 (10), 1561-1567<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1780217688519745305" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Use of a prescription‐based measure of antiretroviral therapy adherence to predict viral rebound in HIV‐infected individuals with viral suppression</a><div class="gs_gray">V Cambiano, FC Lampe, AJ Rodger, CJ Smith, AM Geretti, RK Lodwick, ...</div><div class="gs_gray">HIV medicine 11 (3), 216-224<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9885981251696641144" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:-f6ydRqryjwC" class="gsc_a_at">Simian immunodeficiency virus as a model of human HIV disease</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Reviews in medical virology 9 (1), 57-67<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16410781833627554333" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1</a><div class="gs_gray">CA van Baalen, MR Klein, RC Huisman, MEM Dings, SRK Garde, ...</div><div class="gs_gray">Journal of general virology 77 (8), 1659-1665<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9419136464023913914" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:EkHepimYqZsC" class="gsc_a_at">Evidence of self-sustaining drug resistant HIV-1 lineages among untreated patients in the United Kingdom</a><div class="gs_gray">JL Mbisa, E Fearnhill, DT Dunn, D Pillay, D Asboe, PA Cane, ...</div><div class="gs_gray">Clinical Infectious Diseases 61 (5), 829-836<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=165540547964991260" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:r0BpntZqJG4C" class="gsc_a_at">Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study</a><div class="gs_gray">MCF Prosperi, N Mackie, S Di Giambenedetto, M Zazzi, R Camacho, ...</div><div class="gs_gray">Journal of antimicrobial chemotherapy 66 (8), 1886-1896<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16321251880365230415" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">Optimal use of maraviroc in clinical practice</a><div class="gs_gray">V Soriano, AM Geretti, CF Perno, G Fätkenheuer, D Pillay, J Reynes, ...</div><div class="gs_gray">Aids 22 (17), 2231-2240<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6754488796165765453" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:mB3voiENLucC" class="gsc_a_at">Brain stem encephalitis caused by primary herpes simplex 2 infection in a young woman</a><div class="gs_gray">JW Tang, LJ Coward, NWS Davies, AM Geretti, RS Howard, NP Hirsch, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 74 (9), 1323-1325<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10337064510093147691" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution</a><div class="gs_gray">JA Johnson, AM Geretti</div><div class="gs_gray">Journal of antimicrobial chemotherapy 65 (7), 1322-1326<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10642643736731698262" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings</a><div class="gs_gray">AD Revell, D Wang, R Harrigan, RL Hamers, AMJ Wensing, F Dewolf, ...</div><div class="gs_gray">Journal of antimicrobial chemotherapy 65 (4), 605-607<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5950846913571469413" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:ldfaerwXgEUC" class="gsc_a_at">Science in court: the myth of HIV fingerprinting.</a><div class="gs_gray">AB Abecasis, AM Geretti, J Albert, L Power, M Weait, AM Vandamme</div><div class="gs_gray">The Lancet. Infectious Diseases 11 (2), 78-79<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9726894601835475122" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:ubry08Y2EpUC" class="gsc_a_at">Effectiveness of protease inhibitor/nucleos (t) ide reverse transcriptase inhibitor–based second-line antiretroviral therapy for the treatment of human immunodeficiency virus&nbsp;…</a><div class="gs_gray">AJ Stockdale, MJ Saunders, MA Boyd, LJ Bonnett, V Johnston, ...</div><div class="gs_gray">Clinical infectious diseases 66 (12), 1846-1857<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5752522365876402025" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line&nbsp;…</a><div class="gs_gray">S Aoudjane, M Chaponda, AA González del Castillo, J O'Connor, ...</div><div class="gs_gray">Clinical infectious diseases 59 (11), 1618-1626<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=318342525385077601" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=knKf83IAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">Antiretroviral resistance in clinical practice</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Mediscript<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3689699555005000486,14759190374058113350" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:dhFuZR0502QC" class="gsc_a_at">Human immunodeficiency virus type 1 (HIV-1)-and Epstein-Barr virus-specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1-infected persons</a><div class="gs_gray">AM Geretti, MEM Dings, CACM van Els, CA van Baalen, FJ Wijnholds, ...</div><div class="gs_gray">Journal of Infectious Diseases 174 (1), 34-45<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2267546478443475107" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ</a><div class="gs_gray">A Ruggiero, W De Spiegelaere, A Cozzi-Lepri, M Kiselinova, G Pollakis, ...</div><div class="gs_gray">EBioMedicine 2 (9), 1153-1159<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14343791401028204054" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected persons</a><div class="gs_gray">M Ramaswamy, C Sabin, C McDonald, M Smith, C Taylor, AM Geretti</div><div class="gs_gray">Sexually transmitted diseases 33 (2), 96-101<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13525851873036584025" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:maZDTaKrznsC" class="gsc_a_at">Interactions and management issues in HSV and HIV coinfection</a><div class="gs_gray">M Ramaswamy, AM Geretti</div><div class="gs_gray">Expert review of anti-infective therapy 5 (2), 231-243<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=581067673071491042" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:zCSUwVk65WsC" class="gsc_a_at">HIV gp120 in the lungs of antiretroviral therapy–treated individuals impairs alveolar macrophage responses to pneumococci</a><div class="gs_gray">PJ Collini, MA Bewley, M Mohasin, HM Marriott, RF Miller, AM Geretti, ...</div><div class="gs_gray">American journal of respiratory and critical care medicine 197 (12), 1604-1615<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11328127303390845889" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">The ‘Antiretrovirals, Sexual Transmission Risk and Attitudes’(ASTRA) study. Design, methods and participant characteristics</a><div class="gs_gray">A Speakman, A Rodger, AN Phillips, R Gilson, M Johnson, M Fisher, ...</div><div class="gs_gray">PLoS One 8 (10), e77230<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4600395530042271236" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:0N-VGjzr574C" class="gsc_a_at">Chronic hepatitis B infection in sub-Saharan Africa: a grave challenge and a great hope</a><div class="gs_gray">AJ Stockdale, AM Geretti</div><div class="gs_gray">Transactions of the Royal Society of Tropical Medicine and Hygiene 109 (7&nbsp;…<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17231456754223750513" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">Genotypic tropism testing: evidence-based or leap of faith?</a><div class="gs_gray">PR Harrigan, AM Geretti</div><div class="gs_gray">Aids 25 (2), 257-264<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7560270967702191855" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:TFP_iSt0sucC" class="gsc_a_at">The epidemiology of genital infection with herpes simplex virus types 1 and 2 in genitourinary medicine attendees in inner London</a><div class="gs_gray">M Ramaswamy, C McDonald, C Sabin, M Tenant-Flowers, M Smith, ...</div><div class="gs_gray">Sexually transmitted infections 81 (4), 306-308<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16595707069956717726" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:jU7OWUQzBzMC" class="gsc_a_at">Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London</a><div class="gs_gray">DN Aisyah, L Shallcross, A Hayward, RW Aldridge, S Hemming, S Yates, ...</div><div class="gs_gray">Journal of viral hepatitis 25 (11), 1260-1269<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1986632468001724278" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy</a><div class="gs_gray">AM Geretti, Z Fox, JA Johnson, C Booth, J Lipscomb, LJ Stuyver, ...</div><div class="gs_gray">PloS one 8 (7), e69266<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12566116830592089276" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">Shifting paradigms: the resistance profile of etravirine</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Journal of antimicrobial chemotherapy 62 (4), 643-647<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9254931947283100391" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">National survey of diagnostic services for genital herpes</a><div class="gs_gray">AM Geretti, DW Brown</div><div class="gs_gray">Sexually transmitted infections 81 (4), 316-317<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10343390133697670722" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">Antiretroviral resistance in clinical practice</a><div class="gs_gray">AM Geretti, P Easterbrook</div><div class="gs_gray">International journal of STD &amp; AIDS 12 (3), 145-153<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15530051806888851183" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with&nbsp;…</a><div class="gs_gray">AJ Stockdale, RO Phillips, AM Geretti</div><div class="gs_gray">Gut 65 (5), 882-884<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14859077324873767033" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:rmuvC79q63oC" class="gsc_a_at">Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants</a><div class="gs_gray">M Noguera-Julian, A Cozzi-Lepri, F Di Giallonardo, R Schuurman, ...</div><div class="gs_gray">Clinical microbiology and infection 22 (2), 191-200<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3513224182170746417" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:a0OBvERweLwC" class="gsc_a_at">Comparative evaluation of the Artus HIV-1 QS-RGQ assay and the Abbott RealTime HIV-1 assay for the quantification of HIV-1 RNA in plasma</a><div class="gs_gray">A Garcia-Diaz, W Labbett, GS Clewley, A Guerrero-Ramos, AM Geretti</div><div class="gs_gray">Journal of Clinical Virology 57 (1), 66-69<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16846196466507529718" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:KaMxkj08jr0C" class="gsc_a_at">Hepatitis D prevalence: problems with extrapolation to global population estimates</a><div class="gs_gray">AJ Stockdale, B Kreuels, MRY Henrion, E Giorgi, I Kyomuhangi, ...</div><div class="gs_gray">Gut 69 (2), 396-397<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3019051772810050324" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Detection of the NS3 Q80K polymorphism by Sanger and deep sequencing in hepatitis C virus genotype 1a strains in the UK</a><div class="gs_gray">A Beloukas, S King, K Childs, A Papadimitropoulos, M Hopkins, M Atkins, ...</div><div class="gs_gray">Clinical Microbiology and Infection 21 (11), 1033-1039<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18110638184715768560" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults</a><div class="gs_gray">NE Mackie, DT Dunn, D Dolling, L Garvey, L Harrison, E Fearnhill, ...</div><div class="gs_gray">Aids 27 (14), 2245-2253<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17074962069515291035" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:k_IJM867U9cC" class="gsc_a_at">Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment</a><div class="gs_gray">L Vandekerckhove, C Verhofstede, E Demecheleer, S De Wit, E Florence, ...</div><div class="gs_gray">Journal of antimicrobial chemotherapy 66 (2), 265-272<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16084779120714942462" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">High prevalence of latent tuberculosis and bloodborne virus infection in a homeless population</a><div class="gs_gray">RW Aldridge, AC Hayward, S Hemming, SK Yates, G Ferenando, ...</div><div class="gs_gray">Thorax 73 (6), 557-564<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14528953357576645722" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">HIV: new drugs, new guidelines</a><div class="gs_gray">AM Geretti, M Tsakiroglou</div><div class="gs_gray">Current opinion in infectious diseases 27 (6), 545-553<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=117509036940474708" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:86PQX7AUzd4C" class="gsc_a_at">HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimens</a><div class="gs_gray">M Kiselinova, AM Geretti, E Malatinkova, K Vervisch, A Beloukas, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 70 (12), 3311-3316<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11750019891110797340" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:BqipwSGYUEgC" class="gsc_a_at">Responses to switching to maraviroc-based antiretroviral therapy in treated patients with suppressed plasma HIV-1-RNA load</a><div class="gs_gray">P Vitiello, D Brudney, M MacCartney, A Garcia, C Smith, N Marshall, ...</div><div class="gs_gray">Intervirology 55 (2), 172-178<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4020986335193040758" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:sSrBHYA8nusC" class="gsc_a_at">Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D</a><div class="gs_gray">GM Foster, JC Ambrose, S Hue, VC Delpech, E Fearnhill, AB Abecasis, ...</div><div class="gs_gray">PLoS One 9 (1), e83337<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8402921402854245027" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:isC4tDSrTZIC" class="gsc_a_at">The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors</a><div class="gs_gray">ZV Fox, AM Geretti, J Kjær, UB Dragsted, AN Phillips, J Gerstoft, ...</div><div class="gs_gray">Aids 21 (15), 2033-2042<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3900887130045010157" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">Disseminated neonatal herpes simplex virus (HSV) type 2 infection diagnosed by HSV DNA detection in blood and successfully managed by liver transplantation</a><div class="gs_gray">M Twagira, N Hadzic, M Smith, M Ramaswamy, A Verma, A Dhawan, ...</div><div class="gs_gray">European journal of pediatrics 163 (3), 166-169<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=110720942182578567" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Genotypic antiretroviral drug resistance testing at low viral loads in the UK</a><div class="gs_gray">PA Cane, S Kaye, E Smit, P Tilston, S Kirk, J Shepherd, M Hopkins, ...</div><div class="gs_gray">HIV medicine 9 (8), 673-676<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8523922195838670273" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:blknAaTinKkC" class="gsc_a_at">Novel drug resistance pattern associated with the mutations K70G and M184V in human immunodeficiency virus type 1 reverse transcriptase</a><div class="gs_gray">D Bradshaw, S Malik, C Booth, M Van Houtte, T Pattery, A Waters, ...</div><div class="gs_gray">Antimicrobial agents and chemotherapy 51 (12), 4489-4491<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16819868849649162031" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:GnPB-g6toBAC" class="gsc_a_at">The clinical significance of viral fitness.</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Journal of HIV therapy 10 (1), 6-10<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17055212801414873546" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:8d8msizDQcsC" class="gsc_a_at">CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF</a><div class="gs_gray">S Nightingale, BD Michael, M Fisher, A Winston, M Nelson, S Taylor, ...</div><div class="gs_gray">Cytokine 83, 139-146<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=520359452591132411" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response</a><div class="gs_gray">J Vercauteren, G Beheydt, M Prosperi, P Libin, S Imbrechts, R Camacho, ...</div><div class="gs_gray">PloS one 8 (4), e61436<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=879244101452565796" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:yD5IFk8b50cC" class="gsc_a_at">Development of a real-time multiplex RSV detection assay for difficult respiratory samples, using ultrasone waves and MNAzyme technology</a><div class="gs_gray">D Nauwelaers, L Vijgen, C Atkinson, A Todd, AM Geretti, M Van Ranst, ...</div><div class="gs_gray">Journal of clinical virology 46 (3), 238-243<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15958885000251871818" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Travel-associated acquisition of hepatitis C virus infection in patients receiving haemodialysis</a><div class="gs_gray">A Ghafur, M Raza, W Labbett, A Chawla, C Smith, SL Ngui, A Davenport, ...</div><div class="gs_gray">Nephrology Dialysis Transplantation 22 (9), 2640-2644<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12113713258855835473" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:7wO8s98CvbsC" class="gsc_a_at">Accuracy of self‐report of HIV viral load among people with HIV on antiretroviral treatment</a><div class="gs_gray">J Sewell, M Daskalopoulou, F Nakagawa, FC Lampe, S Edwards, N Perry, ...</div><div class="gs_gray">HIV medicine 18 (7), 463-473<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12393704065211061521" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with&nbsp;…</a><div class="gs_gray">AM Geretti, T Conibear, A Hill, JA Johnson, L Tambuyzer, K Thys, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 69 (4), 1090-1097<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14086351057421024105" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:XiSMed-E-HIC" class="gsc_a_at">Occult hepatitis B virus coinfection in HIV‐positive A frican migrants to the UK: a point prevalence study</a><div class="gs_gray">D Chadwick, T Doyle, S Ellis, D Price, I Abbas, M Valappil, AM Geretti</div><div class="gs_gray">HIV medicine 15 (3), 189-192<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11264153902721786998" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:08ZZubdj9fEC" class="gsc_a_at">Influenza-like illness in acute myocardial infarction patients during the winter wave of the influenza A H1N1 pandemic in London: a case–control study</a><div class="gs_gray">C Warren-Gash, AM Geretti, G Hamilton, RD Rakhit, L Smeeth, ...</div><div class="gs_gray">BMJ open 3 (5), e002604<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1549266636845036435" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Performance of a nurse-led paediatric point of care service for respiratory syncytial virus testing in secondary care</a><div class="gs_gray">AB Khanom, C Velvin, K Hawrami, M Schutten, M Patel, MV Holmes, ...</div><div class="gs_gray">Journal of Infection 62 (1), 52-58<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18397494925856353162" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Predicting antiretroviral drug resistance from the latest or the cumulative genotype</a><div class="gs_gray">F Garcia, M Alvarez, Z Fox, A Garcia-Diaz, V Guillot, M Johnson, ...</div><div class="gs_gray">Antiviral therapy 16 (3), 373<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3266600169396802903" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:RGFaLdJalmkC" class="gsc_a_at">Population trends in the prevalence and patterns of protease resistance related to exposure to unboosted and boosted protease inhibitors</a><div class="gs_gray">UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV ...</div><div class="gs_gray">Antiviral therapy 13 (6), 771-777<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8705418305669128500" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">Immunization of the HIV infected traveller</a><div class="gs_gray">DR Chadwick, AM Geretti</div><div class="gs_gray">Aids 21 (7), 787-794<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2675358805693395218" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Reconstitution of herpes simplex virus-specific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapy</a><div class="gs_gray">M Ramaswamy, A Waters, C Smith, E Hainsworth, G Hardy, M Johnson, ...</div><div class="gs_gray">The Journal of infectious diseases 195 (3), 410-415<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3830864646525769565" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and-experienced patients in the UK</a><div class="gs_gray">K El Bouzidi, E White, JL Mbisa, CA Sabin, AN Phillips, N Mackie, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 71 (12), 3487-3494<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7538206300854342907" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:j7_hQOaDUrUC" class="gsc_a_at">State of the Art in HIV Drug Resistance: Science and Technology Knowledge Gap.</a><div class="gs_gray">CA Boucher, MR Bobkova, AM Geretti, CC Hung, R Kaiser, AG Marcelin, ...</div><div class="gs_gray">AIDS reviews 20 (1), 27-42<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17931135204629457493" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana</a><div class="gs_gray">D Chadwick, M Ankcorn, F Sarfo, R Phillips, Z Fox, A Garcia, L Appiah, ...</div><div class="gs_gray">Journal of antimicrobial chemotherapy 67 (12), 2939-2942<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3447051286676174728" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Human T‐cell lymphotropic virus antibody prevalence in HIV‐1‐infected individuals attending a sexual health clinic in South‐East London</a><div class="gs_gray">FJ Cooke, AM Geretti, M Zuckerman</div><div class="gs_gray">Journal of medical virology 76 (2), 143-145<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=882005548196290212" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:8Xgff_V0N9gC" class="gsc_a_at">Pneumocystis pneumonia, a COVID-19 mimic, reminds us of the importance of HIV testing in COVID-19</a><div class="gs_gray">S Kelly, L Waters, M Cevik, S Collins, J Lewis, MS Wu, TJ Blanchard, ...</div><div class="gs_gray">Clinical Medicine 20 (6), 590<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=445097326533767531" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:SjuI4pbJlxcC" class="gsc_a_at">Epidemiology of hepatitis B, C and D in Malawi: systematic review</a><div class="gs_gray">AJ Stockdale, C Mitambo, D Everett, AM Geretti, MA Gordon</div><div class="gs_gray">BMC infectious diseases 18 (1), 1-10<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6784058122673271457" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Mojj43d5GZwC" class="gsc_a_at">Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV‐infected adults in G hana</a><div class="gs_gray">S King, K Adjei‐Asante, L Appiah, D Adinku, A Beloukas, M Atkins, ...</div><div class="gs_gray">Journal of viral hepatitis 22 (5), 461-468<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10264287269302624673" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Transmission of HIV drug resistance: lessons from sensitive screening assays</a><div class="gs_gray">AM Geretti, R Paredes, MJ Kozal</div><div class="gs_gray">Current opinion in infectious diseases 28 (1), 23-30<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9041617472433932299" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:f2IySw72cVMC" class="gsc_a_at">O121. Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing</a><div class="gs_gray">LPR Vandekerckhove, AMJ Wensing, R Kaiser, F Brun-Vezinet, B Clotet, ...</div><div class="gs_gray">Journal of the International AIDS Society 13 (4), 1-2<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14630288867343460364" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:DkZNVXde3BIC" class="gsc_a_at">The use of phylogenetic analysis as evidence in criminal investigation of HIV transmission</a><div class="gs_gray">EJ Bernard, Y Azad, AM Vandamme, M Weait, AM Geretti</div><div class="gs_gray">NAT. London<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1018289600674846148" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Resistance to non-nucleoside reverse transcriptase inhibitors</a><div class="gs_gray">N Mackie</div><div class="gs_gray">Antiretroviral resistance in clinical practice<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6627418323333876227" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">Adenovirus viraemia and dissemination unresponsive to antiviral therapy in advanced HIV-1 infection</a><div class="gs_gray">G Nebbia, A Chawla, M Schutten, C Atkinson, M Raza, M Johnson, ...</div><div class="gs_gray">Aids 19 (12), 1339-1340<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15676779913880330281" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:rO6llkc54NcC" class="gsc_a_at">Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection.</a><div class="gs_gray">AM Geretti, E Hulskotte, AD Osterhaus</div><div class="gs_gray">Journal of General Virology 79 (3), 415-421<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18130569504033004954" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">CD8+ cytotoxic T lymphocytes of a cynomolgus macaque infected with simian immunodeficiency virus (SIV) mac32H-J5 recognize a nine amino acid epitope in SIV Gag p26.</a><div class="gs_gray">AM Geretti, EG Hulskotte, ME Dings, CA van Baalen, G van Amerongen, ...</div><div class="gs_gray">Journal of general virology 78 (4), 821-824<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6683228509994347438" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:BrOSOlqYqPUC" class="gsc_a_at">Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance</a><div class="gs_gray">PL Tzou, SY Rhee, D Descamps, DS Clutter, B Hare, O Mor, M Grude, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 75 (1), 170-182<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12051326929987674028" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:eO3_k5sD8BwC" class="gsc_a_at">Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group</a><div class="gs_gray">D Bradshaw, JL Mbisa, AM Geretti, BJ Healy, GS Cooke, GR Foster, ...</div><div class="gs_gray">Journal of Infection 79 (6), 503-512<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18277407527069749555,3916123430732978048" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:D03iK_w7-QYC" class="gsc_a_at">Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa</a><div class="gs_gray">D Chadwick, A Stanley, S Sarfo, L Appiah, M Ankcorn, G Foster, ...</div><div class="gs_gray">Aids 27 (1), 139-141<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1743591901176059134" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Kinetics and Specificities of the T Helper–Cell Response to GP120 in the Asymptomatic Stage of HIV–1 Infection</a><div class="gs_gray">AM Geretti, CA Van Baalen, JCC Borleffs, C Van Els, ADME OSTERHAUS</div><div class="gs_gray">Scandinavian journal of immunology 39 (4), 355-362<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9813605697950581221" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:kw52XkFRtyQC" class="gsc_a_at">European AIDS clinical society standard of care meeting on HIV and related coinfections: the Rome statements</a><div class="gs_gray">C Mussini, A Antinori, S Bhagani, T Branco, M Brostrom, N Dedes, ...</div><div class="gs_gray">HIV medicine 17 (6), 445-452<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16319945283494096292" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:MAUkC_7iAq8C" class="gsc_a_at">Human immunodeficiency viruses.</a><div class="gs_gray">D Pillay, AM Geretti, RA Weiss</div><div class="gs_gray">Principles and practice of clinical virology, 897-938<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=379137460456985493" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Primary herpes simplex virus type‐2 infection as a cause of liver failure after liver transplantation</a><div class="gs_gray">G Nebbia, FM Mattes, M Ramaswamy, A Quaglia, G Verghese, ...</div><div class="gs_gray">Transplant infectious disease 8 (4), 229-232<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1978493957369450455" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Resistance assays</a><div class="gs_gray">M Schutten</div><div class="gs_gray">Antiretroviral resistance in clinical practice<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7543031478094278136" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:35N4QoGY0k4C" class="gsc_a_at">Detection and typing of herpes simplex DNA in genital swabs by real-time polymerase chain reaction</a><div class="gs_gray">M Ramaswamy, M Smith, AM Geretti</div><div class="gs_gray">Journal of virological methods 126 (1-2), 203-206<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=692116862191787864" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Prevalence of antiretroviral resistance in a South London cohort of treatment-naive HIV-1-infected patients</a><div class="gs_gray">AM Geretti, M Smith, N Osner, S O'Shea, I Chrystie, P Easterbrook, ...</div><div class="gs_gray">Aids 15 (8), 1082-1084<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11804220219901023061" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:rbm3iO8VlycC" class="gsc_a_at">Safety and pharmacokinetic characterization of nacubactam, a novel β-lactamase inhibitor, alone and in combination with meropenem, in healthy volunteers</a><div class="gs_gray">NL Mallalieu, E Winter, S Fettner, K Patel, E Zwanziger, G Attley, ...</div><div class="gs_gray">Antimicrobial agents and chemotherapy 64 (5), e02229-19<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15496074928603451549" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:silx2ntsSuwC" class="gsc_a_at">Outcomes of COVID-19 related hospitalisation among people with HIV in the ISARIC WHO Clinical Characterisation Protocol UK Protocol: prospective observational study</a><div class="gs_gray">AM Geretti, AJ Stockdale, SH Kelly, M Cevik, S Collins, L Waters, G Villa, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8282359317767883461" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:XiVPGOgt02cC" class="gsc_a_at">Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana</a><div class="gs_gray">FS Sarfo, A Kasim, R Phillips, AM Geretti, DR Chadwick</div><div class="gs_gray">Journal of Infection 69 (5), 481-489<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7857993119748406001" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:_B80troHkn4C" class="gsc_a_at">Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study</a><div class="gs_gray">DI Dolling, DT Dunn, KA Sutherland, D Pillay, JL Mbisa, CM Parry, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 68 (10), 2339-2343<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17311169328355976850" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:5icHVeHT4IsC" class="gsc_a_at">Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana</a><div class="gs_gray">G Villa, RO Phillips, C Smith, AJ Stockdale, A Beloukas, LT Appiah, ...</div><div class="gs_gray">Journal of Infection 76 (6), 515-521<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1764594090882478521" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">No evidence that HIV-1 subtype C infection compromises the efficacy of tenofovir-containing regimens: cohort study in the United Kingdom</a><div class="gs_gray">E White, E Smit, D Churchill, S Collins, C Booth, A Tostevin, C Sabin, ...</div><div class="gs_gray">The Journal of infectious diseases 214 (9), 1302-1308<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12876243149092321740" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">HLA-A is a predictor of hepatitis B e antigen status in HIV-positive African adults</a><div class="gs_gray">PC Matthews, JM Carlson, A Beloukas, A Malik, P Jooste, A Ogwu, ...</div><div class="gs_gray">The Journal of infectious diseases 213 (8), 1248-1252<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2658443923390077557" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">Prevalence and patterns of raltegravir resistance in treated patients in Europe</a><div class="gs_gray">AM Geretti, E Fearnhill, F Ceccherini-Silberstein, A Sonnerborg, ...</div><div class="gs_gray">Antiviral Therapy 15 (4), A62-A62<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9390464733666166656" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:70eg2SAEIzsC" class="gsc_a_at">Genotypic prediction of viral co-receptor tropism: correlation with enhanced Trofile</a><div class="gs_gray">A Strang, J Cameron, C Booth, A Garcia-Diaz, AM Geretti</div><div class="gs_gray">7th European HIV Drug Resistance Workshop. Stockholm, Sweden, 25-27<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2586107717678196276" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:dshw04ExmUIC" class="gsc_a_at">Emergence of the H208Y mutation in the reverse transcriptase (RT) of HIV-1 in association with nucleoside RT inhibitor therapy</a><div class="gs_gray">G Nebbia, CA Sabin, DT Dunn, AM Geretti</div><div class="gs_gray">Journal of antimicrobial chemotherapy 59 (5), 1013-1016<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17782275125937017759" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:NJ774b8OgUMC" class="gsc_a_at">Clinical cut-offs in the interpretation of phenotypic resistance</a><div class="gs_gray">CF Perno, A Bertoli</div><div class="gs_gray">Antiretroviral resistance in clinical practice<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15768324291307801204" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:2v_ZtQDX9iAC" class="gsc_a_at">Outcomes of coronavirus disease 2019 (COVID-19) related hospitalization among people with human immunodeficiency virus (HIV) in the ISARIC World Health Organization (WHO&nbsp;…</a><div class="gs_gray">AM Geretti, AJ Stockdale, SH Kelly, M Cevik, S Collins, L Waters, G Villa, ...</div><div class="gs_gray">Clinical Infectious Diseases<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7813461916852769521" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:IRz6iEL74y4C" class="gsc_a_at">A contaminant-free assessment of Endogenous Retroviral RNA in human plasma</a><div class="gs_gray">T Karamitros, D Paraskevis, A Hatzakis, M Psichogiou, I Elefsiniotis, ...</div><div class="gs_gray">Scientific reports 6 (1), 1-12<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15745611867486950960" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:WqliGbK-hY8C" class="gsc_a_at">Epidemiology of HBV infection in a cohort of Ugandan HIV-infected patients and rate and pattern of lamivudine-resistant HBV infection in patients receiving antiretroviral therapy</a><div class="gs_gray">G Calisti, R Muhindo, Y Boum, LA Wilson, GM Foster, AM Geretti, ...</div><div class="gs_gray">Transactions of The Royal Society of Tropical Medicine and Hygiene 109 (11&nbsp;…<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3094911736331962310,1584183018701188561" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">The impact of HIV drug resistance testing on changes to treatment</a><div class="gs_gray">L Bansi, C Smith, A Phillips, S Kirk, AM Geretti, M Johnson, N Mackie, ...</div><div class="gs_gray">Aids 25 (5), 603-610<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5859183748819941876" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">Antiretroviral resistance.</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Journal of HIV therapy 11 (4), 72-73<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1558069491912604462" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:M05iB0D1s5AC" class="gsc_a_at">Primary antiretroviral resistance in newly diagnosed patients with established heterosexually acquired HIV-1</a><div class="gs_gray">AM Geretti, M Smith, C Watson, J Mullen, N Osner, S O'Shea, I Chrystie, ...</div><div class="gs_gray">Aids 16 (17), 2358-2360<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11787410747291449722" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Decline of simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in the peripheral blood of long-term nonprogressing macaques infected with SIVmac32H-J5</a><div class="gs_gray">AM Geretti, EGJ Hulskotte, MEM Dings, CA van Baalen, ...</div><div class="gs_gray">The Journal of infectious diseases 180 (4), 1133-1141<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12701149436734583297" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:MhiOAD_qIWkC" class="gsc_a_at">Virological failure and development of new resistance mutations according to CD 4 count at combination antiretroviral therapy initiation</a><div class="gs_gray">S Jose, K Quinn, D Dunn, A Cox, C Sabin, S Fidler, ...</div><div class="gs_gray">HIV medicine 17 (5), 368-372<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16339040837045696924" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:sszUF3NjhM4C" class="gsc_a_at">Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy</a><div class="gs_gray">CL Alesandro, D Dunn, D Pillay, CA Sabin, E Fearnhill, AM Gerettsabini, ...</div><div class="gs_gray">Clinical Infectious Diseases 50 (9), 1275-1285<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7762251123966590105" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:NyGDZy8z5eUC" class="gsc_a_at">Hepatitis B virus drug resistance</a><div class="gs_gray">A Beloukas, AM Geretti</div><div class="gs_gray">Antimicrobial Drug Resistance, 1227-1242<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7876433791112110351" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:35r97b3x0nAC" class="gsc_a_at">Interpretation algorithms</a><div class="gs_gray">T Sing, M Däumer</div><div class="gs_gray">Antiretroviral Resistance in Clinical Practice<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4115369206251961066" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:abG-DnoFyZgC" class="gsc_a_at">Virus replication and evolution drive the kinetics and specificity of SIV‐specific cytotoxic T lymphocytes</a><div class="gs_gray">AM Geretti, ADME Osterhaus</div><div class="gs_gray">Immunological reviews 183 (1), 109-114<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8206198998547632723" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:P5F9QuxV20EC" class="gsc_a_at">Simian immunodeficiency virus (SIV)-specific CD8+ cytotoxic T lymphocyte responses of naive and vaccinated cynomolgus macaques infected with SIVmac32H (J5): quantitative&nbsp;…</a><div class="gs_gray">AM Geretti, EGJ Hulskotte, MEM Dings, CA van Baalen, ...</div><div class="gs_gray">Vaccine 15 (11), 1269-1275<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5845474937542361222" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Preservation of phenotype and function of positively selected virus-specific CD8+ T lymphocytes following anti-Fab detachment from immunomagnetic beads</a><div class="gs_gray">AM Geretti, C Van Els, CA Van Baalen, MCM Poelen, A Osterhaus</div><div class="gs_gray">Journal of immunological methods 161 (1), 129-133<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11244845972326566028" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:mWEH9CqjF64C" class="gsc_a_at">Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa</a><div class="gs_gray">G Villa, A Abdullahi, D Owusu, C Smith, M Azumah, L Sayeed, H Austin, ...</div><div class="gs_gray">EClinicalMedicine 18, 100231<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=554129441270510303" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:PaBasH6fAo0C" class="gsc_a_at">Factors associated with persistence of plasma HIV-1 RNA during long-term continuously suppressive firstline antiretroviral therapy</a><div class="gs_gray">A Ruggiero, A Cozzi-Lepri, A Beloukas, D Richman, S Khoo, A Phillips, ...</div><div class="gs_gray">Open forum infectious diseases 5 (2), ofy032<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2652075903578783716" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:_xSYboBqXhAC" class="gsc_a_at">Computational models developed without a genotype for resource-poor countries predict response to HIV treatment with 82% accuracy</a><div class="gs_gray">AD Revell, D Wang, R Harrigan, J Gatell, L Ruiz, S Emery, MJ Pérez-Elías, ...</div><div class="gs_gray">Antiviral Therapy 14 (Supplement 1)<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2127552051255766680" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug&nbsp;…</a><div class="gs_gray">AM Geretti, E White, C Orkin, A Tostevin, P Tilston, D Chadwick, C Leen, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 74 (3), 746-753<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1379492660773189184" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Ade32sEp0pkC" class="gsc_a_at">Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos (t) ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting</a><div class="gs_gray">A Abdullahi, OM Fopoussi, J Torimiro, M Atkins, C Kouanfack, AM Geretti</div><div class="gs_gray">Open forum infectious diseases 5 (10), ofy251<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5327219504023235654" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:IaI1MmNe2tcC" class="gsc_a_at">Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group</a><div class="gs_gray">JD Kowalska, K Aebi‐Popp, M Loutfy, FA Post, MJ Perez‐Elias, ...</div><div class="gs_gray">HIV medicine 19 (2), 167-173<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13509574292758274850" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:4xDN1ZYqzskC" class="gsc_a_at">Out of focus: tailoring the cascade of care to the needs of women living with HIV</a><div class="gs_gray">AM Geretti, M Loutfy, A D'Arminio Monforte, I Latysheva, MJ Perez Elias, ...</div><div class="gs_gray">HIV medicine 18, 3-17<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15980367219829178046" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">Undiagnosed HIV infection in patients with viral hepatitis</a><div class="gs_gray">AM Geretti, S Madge, M Posner, G Dusheiko, M Jacobs</div><div class="gs_gray">Bmj 336 (7659), 1451-1452<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5921435305610067902" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Treatment-emergent gag cleavage site mutations during virological failure of ritonavir-boosted protease inhibitors</a><div class="gs_gray">A Garcia-Diaz, Z Fox, UB Dragsted, J Kjaer, N Clumeck, A Philips, ...</div><div class="gs_gray">ANTIVIRAL THERAPY 13 (4), A80-A80<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13844158691267504324" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:6yz0xqPARnAC" class="gsc_a_at">NRTI resistance associated with the RT mutation K70E in HIV-1</a><div class="gs_gray">M Van Houtte, M Staes, AM Geretti, T Pattery, L Bacheler</div><div class="gs_gray">Antiviral Therapy 11 (5), S160<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4560739087177831331" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">Resistance to entry inhibitors</a><div class="gs_gray">E Poveda, V Soriano</div><div class="gs_gray">Antiretroviral resistance in clinical practice<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12402542630279907316" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">The significance of subtype-related genetic variability: controversies and unanswered questions</a><div class="gs_gray">R Camacho</div><div class="gs_gray">Antiretroviral resistance in clinical practice<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6069720325668925546" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:UxriW0iASnsC" class="gsc_a_at">High levels of discordance between sequencing and serological subtyping in a predominantly non-B subtype HIV-1 infected cohort</a><div class="gs_gray">M Smith, AM Geretti, N Osner, P Easterbrook, M Zuckerman</div><div class="gs_gray">Journal of clinical virology 33 (4), 312-318<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18162718433938837460" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:SP6oXDckpogC" class="gsc_a_at">Prevalence of reduced drug susceptibility in treatment-naive patients in the UK</a><div class="gs_gray">DT Dunn, H Green, R Matthias, P Woodburn, R Gifford, I Chrystie, ...</div><div class="gs_gray">Antivir Ther 9, S107<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4437266718447840064" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:aIdbFUkbNIkC" class="gsc_a_at">Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK</a><div class="gs_gray">JL Mbisa, J Ledesma, P Kirwan, DF Bibby, C Manso, A Skingsley, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 75 (11), 3311-3318<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6769308997491378618" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:QsaTk4IG4EwC" class="gsc_a_at">Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective&nbsp;…</a><div class="gs_gray">P Lampertico, T Berg, M Buti, A Pathil, J Petersen, SD Ryder, F Zoulim, ...</div><div class="gs_gray">Alimentary pharmacology &amp; therapeutics 52 (3), 500-512<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3807922325160673206" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:geHnlv5EZngC" class="gsc_a_at">ART use, viral suppression, and sexual behaviour among HIV-diagnosed MSM in the UK: results from the Antiretrovirals, Sexual Transmission Risk and Attitudes (ASTRA) Study.</a><div class="gs_gray">F Lampe, A Speakman, A Phillips, L Sherr, R Gilson, M Johnson, M Fisher, ...</div><div class="gs_gray">Journal of the International AIDS Society 15, 14-15<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9682486858066532856" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Detecting HIV-1 superinfection by pol gene population sequencing among untreated HIV-1-infected men who experience sudden rises in plasma HIV-1 RNA load</a><div class="gs_gray">T Doyle, AM Garcia-Diaz, J Ambrose, A Strang, V Cambiano, M Johnson, ...</div><div class="gs_gray">Aids 25 (4), 542-544<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=992717655212456549" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Use of a genotypic assay for prediction of HIV-1 co-receptor tropism and guiding the use of CCR5 antagonists in clinical practice</a><div class="gs_gray">MJ Macartney, J Cameron, A Strang, A Garcia, C Booth, N Marshall, ...</div><div class="gs_gray">8th European HIV Drug Resistance Workshop, 17-19<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5778974560682572795" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:p2g8aNsByqUC" class="gsc_a_at">Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the <i>CYP2B6</i> 516 TT polymorphism</a><div class="gs_gray">A Garcia-Diaz, C Blok, S Madge, C Booth, M Tyrer, S Bonora, T Mahungu, ...</div><div class="gs_gray">Journal of antimicrobial chemotherapy 62 (6), 1188-1190<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10775522668254887178" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:yB1At4FlUx8C" class="gsc_a_at">Benefits of resistance testing</a><div class="gs_gray">D Descamps, F Brun-Vézinet</div><div class="gs_gray">Antiretroviral Resistance in Clinical Practice<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3125091287772806920" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:738O_yMBCRsC" class="gsc_a_at">Transmitted drug resistance clusters with the infecting HIV-1 subtype: a single centre analysis of all new HIV-1 diagnoses in London</a><div class="gs_gray">A Garcia-Diaz, C Booth, G Nebbia, A Chawla, M Johnson, AM Geretti</div><div class="gs_gray">ANTIVIRAL THERAPY 11 (5), S126-S126<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12630525776583651132" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Essential benefits of nucleoside analogue regimens in failing therapy.</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Journal of HIV therapy 9 (2), 28-33<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7078736694021445519" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Xl6nMSl579sC" class="gsc_a_at">A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet&nbsp;…</a><div class="gs_gray">CC Iwuji, D Churchill, S Bremner, N Perry, Y To, D Lambert, C Bruce, ...</div><div class="gs_gray">BMC infectious diseases 20 (1), 1-12<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14716558360443823315" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:CdxZDUztZiMC" class="gsc_a_at">Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring</a><div class="gs_gray">G Villa, RO Phillips, C Smith, AJ Stockdale, A Ruggiero, A Beloukas, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 73 (11), 3148-3157<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6994262501936224654" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:DBa1UEJaJKAC" class="gsc_a_at">Point-of-care screening for a current hepatitis C virus infection: influence on uptake of a concomitant offer of HIV screening</a><div class="gs_gray">AM Geretti, H Austin, G Villa, D Hungerford, C Smith, P Davies, J Williams, ...</div><div class="gs_gray">Scientific reports 8 (1), 1-8<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9633485331960679256" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:LI9QrySNdTsC" class="gsc_a_at">Efficacy of once daily darunavir/ritonavir in PI-Naïve, NNRTI-experienced patients in the ODIN trial</a><div class="gs_gray">AM Geretti, M Moeketsi, R Demasi, Y van Delft, P Mohammed</div><div class="gs_gray">AIDS research and treatment 2015<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13906934799436974022" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:W5xh706n7nkC" class="gsc_a_at">Depression and virological status among UK HIV outpatients: results from a multicentre study</a><div class="gs_gray">F Lampe, A Speakman, A Phillips, L Sherr, R Gilson, M Johnson, M Fisher, ...</div><div class="gs_gray">Hiv Medicine 13 (S1), 4-4<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3811561104165717202" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">Predicting NNRTI resistance: do polymorphisms matter</a><div class="gs_gray">N Mackie, L Garvey, A Geretti, L Harrison, P Tilston, C Sabin</div><div class="gs_gray">18th Conference on Retroviruses and Opportunistic Infections 27<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=145560881747639393" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">European consensus on clinical use and interpretation of HIV-1 tropism testing: LBPE1. 2/9</a><div class="gs_gray">L Vandekerckhove, A Wensing, R Kaiser, F Brun-Vezinet, B Clotet, ...</div><div class="gs_gray">Hiv Medicine 10, 48-49<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8097159267379679947" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:WbkHhVStYXYC" class="gsc_a_at">HIV antibody avidity testing to identify recent infection in newly diagnosed HIV-1 seropositive persons infected with diverse HIV-1 subtypes</a><div class="gs_gray">A Chawla, G Murphy, C Donnelly, CL Booth, M Johnson, JV Parry, ...</div><div class="gs_gray">Journal of Clinical Microbiology<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2919134359909707848" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:u9iWguZQMMsC" class="gsc_a_at">Neural networks are more accurate predictors of virologic response to antiretroviral therapy than rules-based genotype interpretation systems</a><div class="gs_gray">BA Larder, AM Geretti, L Monno, C Torti, A Revell, D Wang, R Harrigan, ...</div><div class="gs_gray">Thirteenth Conference on Retroviruses and Opportunistic Infections, Denver&nbsp;…<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13602709923853763155" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:pS0ncopqnHgC" class="gsc_a_at">Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European survey</a><div class="gs_gray">A De Luca, P Pezzotti, C Boucher, M Döring, F Incardona, R Kaiser, ...</div><div class="gs_gray">PloS one 14 (11), e0225381<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13871554553682749372" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:YsrPvlHIBpEC" class="gsc_a_at">Determining the origins of human immunodeficiency virus type 1 drug-resistant minority variants in people who are recently infected using phylogenetic reconstruction</a><div class="gs_gray">JL Mbisa, P Kirwan, A Tostevin, J Ledesma, DF Bibby, A Brown, R Myers, ...</div><div class="gs_gray">Clinical Infectious Diseases 69 (7), 1136-1143<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11185600717269542071" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:otzGkya1bYkC" class="gsc_a_at">Hepatitis C Virus (HCV) RNA screening and sequencing using dry plasma spots</a><div class="gs_gray">AM Geretti, S King, K Adjei-Asante, LT Appiah, DO Owusu, FS Sarfo, ...</div><div class="gs_gray">Journal of Clinical Virology 97, 18-21<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15642240374568946772" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:p__nRnzSRKYC" class="gsc_a_at">BASHH/EAGA position statement on the HIV window period</a><div class="gs_gray">DP Webster, M Donati, AM Geretti, LJ Waters, B Gazzard, K Radcliffe</div><div class="gs_gray">International journal of STD &amp; AIDS 26 (10), 760-761<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11285065364098886399" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">HIV-1 Subtype and Virological Response to Antiretroviral Therapy: a confirmatory analysis</a><div class="gs_gray">DI Dolling, DT Dunn, AM Geretti, CA Sabin, ...</div><div class="gs_gray">Clinical infectious diseases 56 (1), 162-163<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10703257942488427387" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:D_sINldO8mEC" class="gsc_a_at">Patterns of HIV testing at a London teaching hospital between 2004 and 2007</a><div class="gs_gray">S Madge, C Smith, A Evans, G Clewley, MA Johnson, AM Geretti</div><div class="gs_gray">International journal of STD &amp; AIDS 22 (12), 730-733<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6137611297007285917" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:1qzjygNMrQYC" class="gsc_a_at">HIV testing and monitoring</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Medicine 37 (7), 326-329<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16945687906287090200" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">Travel-associated acquisition of hepatitis C—implications for the renal transplant waiting list</a><div class="gs_gray">D Parsons, RA Coward, A Woywodt</div><div class="gs_gray">Nephrology Dialysis Transplantation 23 (6), 2104-2104<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17371781285837417106" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Prevalence and patterns of antiretroviral drug resistance at low plasma HIV RNA load levels</a><div class="gs_gray">AM Geretti, A Phillips, S Kaye, C Booth, A Garcia, N Mackie</div><div class="gs_gray">INT MEDICAL PRESS LTD 13 (4), A156-A156<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7231539206198790061" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:vRqMK49ujn8C" class="gsc_a_at">Association between resistance and CD4 count change in patients on ART with ongoing viraemia</a><div class="gs_gray">ZV Fox, AM Geretti, B Clotet, A Cozzi-Lepri, T Hill, H Green, CA Sabin, ...</div><div class="gs_gray">XVI International HIV Drug Resistance Workshop<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3822659517324654245" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:RoXSNcbkSzsC" class="gsc_a_at">Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom</a><div class="gs_gray">S Burns, S Cameron, P Cane, I Chrystie, D Churchill, V Delpech, D Pillay, ...</div><div class="gs_gray">AIDS 21 (8), 1035-1039<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16393378034196254565" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:PyEswDtIyv0C" class="gsc_a_at">Resistance to non-nucleoside reverse transcriptase inhibitors</a><div class="gs_gray">AM Geretti, N Mackie</div><div class="gs_gray">Antiretroviral Resistance in Clinical Practice. Mediscript, London<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3906338122887036652" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Database analyses of predictors of resistance</a><div class="gs_gray">C Sabin</div><div class="gs_gray">Antiretroviral Resistance in Clinical Practice<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6706437140685403049" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:LPZeul_q3PIC" class="gsc_a_at">Risk group predicts the prevalence of primary resistance amongst newly diagnosed HIV-infected patients presenting with established infection according to the STARHS algorithm</a><div class="gs_gray">AM Geretti, C Booth, WA Labbett, G Murphy, M Johnson</div><div class="gs_gray">ANTIVIRAL THERAPY 10 (4), S131-S131<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=606752016291715558" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:8AbLer7MMksC" class="gsc_a_at">Risk of development of drug resistance in patients starting antiretroviral therapy with three or more drugs in routine clinical practice</a><div class="gs_gray">AN Phillips, D Dunn, C Sabin, A Pozniak, R Matthias, AM Geretti, J Clarke, ...</div><div class="gs_gray">INT MEDICAL PRESS LTD 9 (4), U107-U107<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10090663407896092352" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:69ZgNCALVd0C" class="gsc_a_at">Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation</a><div class="gs_gray">OT Stirrup, D Asboe, A Pozniak, CA Sabin, R Gilson, NE Mackie, ...</div><div class="gs_gray">HIV medicine 21 (5), 309-321<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2364997074142837758" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:2l5NCbZemmgC" class="gsc_a_at">A novel liver-directed locked nucleic acid targeting PD-L1 expression reverts HBV-specific immune tolerance and induces sustained clearance of HBV infection</a><div class="gs_gray">J Zhao, L Pedersen, J Blaising, M Ait-Goughoulte, F Shen, Y Yu, J Walther, ...</div><div class="gs_gray">Hepatology 70, 431A-431A<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1914906413269414964" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:lgwcVrK6X84C" class="gsc_a_at">Hepatitis C virus infection in vulnerable populations: a seroprevalence study of homeless, people who inject drugs and prisoners in London, UK</a><div class="gs_gray">DN Aisyah, L Shallcross, A Hayward, RW Aldridge, S Hemming, S Yates, ...</div><div class="gs_gray">The Lancet 390, S18<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2798755313271433536" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:9c2xU6iGI7YC" class="gsc_a_at">HIV Transmission During Condomless Sex With a Seropositive Partner With Suppressed Infection—Reply</a><div class="gs_gray">AM Geretti, AJ Rodger, J Lundgren</div><div class="gs_gray">Jama 316 (19), 2045-2045<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18322667738777591880" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:v1_lew4L6wgC" class="gsc_a_at">Impact of transmitted thymidine analogue mutations on responses to first-line ART</a><div class="gs_gray">AM Geretti, E White, A Beloukas, C Orkin, A Tostevin, P Tilston, ...</div><div class="gs_gray">23rd Conference on retroviruses and opportunistic infections (CROI), 22-25<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13216522031282104092" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:5ugPr518TE4C" class="gsc_a_at">S61 High levels of latent TB infection, blood borne viruses, poor treatment outcomes and unmet need among hard to reach groups in London: the TB reach study</a><div class="gs_gray">G Ferenando, S Hemming, S Yates, L Possas, E Garber, V Gant, ...</div><div class="gs_gray">Thorax 69 (Suppl 2), A34-A34<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6246958513888146820" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:gsN89kCJA0AC" class="gsc_a_at">The importance of HIV RNA detection below 50 copies per mL in HIV-positive patients on antiretroviral therapy: an observational study</a><div class="gs_gray">T Doyle, C Smith, P Vitiello, V Cambiano, M Johnson, A Owen, A Phillips, ...</div><div class="gs_gray">The Lancet 383, S44<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13212327315477740263" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:HE397vMXCloC" class="gsc_a_at">Impact of baseline HIV-1 integrase polymorphisms on virological outcome in a large European cohort of patients starting a raltegravir-containing regimen</a><div class="gs_gray">D Armenia, I Malet, L Fabeni, S Reigadas, V Guillot, D Dunn, R Kaiser, ...</div><div class="gs_gray">Antiviral therapy 16 (4), A69-A69<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8887595536504897910" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Forgotten, but not gone</a><div class="gs_gray">E Sanchez, SF Atabani, J Kaplanova, P Griffiths, AM Geretti, T Haque</div><div class="gs_gray">BMJ 341<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15128646153397656758" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">Pairwise comparison of genotypic tropism prediction between 1 reference centre and 10 European laboratories</a><div class="gs_gray">S Sierra, M Balduin, M Zazzi, A Sonnerborg, AM Geretti, ...</div><div class="gs_gray">ANTIVIRAL THERAPY 15, A22-A22<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11966703133818178133" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:yFnVuubrUp4C" class="gsc_a_at">The Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 version 2.0 assay for HIV-1 RNA load measurement in plasma shows improved detection of non-B subtypes and increased levels of&nbsp;…</a><div class="gs_gray">A Geretti, W Tong, Z Fox, W Labbett, S O'Shea, I Chrystie, E Smit</div><div class="gs_gray">Hiv Medicine 10<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14270888276498329376" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">Comparison of population and 454 genotyping and Trofile phenotyping for tropism determination in patients selected for maraviroc initiation</a><div class="gs_gray">L Vandekerckhove, C Verhofstede, I Vandenbroucke, C Booth, ...</div><div class="gs_gray">18th International HIV Drug Resistance Workshop 14 (4), 112<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4453907712848629183" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">New horizons in antiretroviral drug resistance</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Journal of HIV therapy 12 (4), 81-83<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1526825679680033302" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ce2CqMG-AY4C" class="gsc_a_at">Characterization of a novel drug-resistance pattern associated with the mutations K70G and M184V in HIV-1 reverse transcriptase</a><div class="gs_gray">D Bradshaw, S Malik, C Booth, M Van Houtte, T Pattery, A Waters, ...</div><div class="gs_gray">Antimicrobial Agents and Chemotherapy<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17048776379555006414" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Tenofovir drug resistance and mutational pathways associated with the RT mutation K70E in HIV-1</a><div class="gs_gray">M Van Houtte, M Staes, AM Geretti, T Pattery, L Bacheler</div><div class="gs_gray">Program and abstracts of the 4th European HIV Drug Resistance Workshop<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16098399998428082122" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Pharmacokinetic implications of resistance</a><div class="gs_gray">M Boffito</div><div class="gs_gray">Antiretroviral resistance in clinical practice<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7991687487875262651" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:eflP2zaiRacC" class="gsc_a_at">Estimating resistance in drug experienced patients in the UK</a><div class="gs_gray">D Pillay, H Green, B Gazzard, A Pozniak, R Matthias, M Johnson, ...</div><div class="gs_gray">INT MEDICAL PRESS LTD 9 (4), U69-U70<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6554085091852022744" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Hck25ST_3aIC" class="gsc_a_at">Algorithm for the use of genotypic HIV-1 resistance data Rega v8. 0.2©, Leuven, 16 June 2009</a><div class="gs_gray">K Van Laethem, AM Geretti, R Camacho, AM Vandamme</div><div class="gs_gray">Target 1, 1<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16109350547087199606" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:65Yg0jNCQDAC" class="gsc_a_at">HBV‐RNA Co‐amplification May Influence HBV DNA Viral Load Determination</a><div class="gs_gray">B Maasoumy, AM Geretti, A Frontzek, H Austin, G Aretzweiler, ...</div><div class="gs_gray">Hepatology communications 4 (7), 983-997<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2262954222191133650" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:48xauSegjOkC" class="gsc_a_at">Introduction and general principles</a><div class="gs_gray">T Solomon, AM Geretti</div><div class="gs_gray">Hunter's Tropical Medicine and Emerging Infectious Diseases, 228-231<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10318920920201156338" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:qwy9JoKyICEC" class="gsc_a_at">Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz+ tenofovir+ emtricitabine for HIV</a><div class="gs_gray">OT Stirrup, CA Sabin, AN Phillips, I Williams, D Churchill, A Tostevin, ...</div><div class="gs_gray">Journal of virus eradication 5 (4), 204-211<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4466533239849855873" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:mUJArPsKIAAC" class="gsc_a_at">An apparent paradox: resistance mutations in HIV-1 DNA predict improved virological responses to antiretroviral therapy</a><div class="gs_gray">AM Geretti, A Abdullahi, O Mafotsing Fopoussi, L Bonnett, VF Defo, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 74 (10), 3011-3015<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=690128691288798347" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ziOE8S1-AIUC" class="gsc_a_at">Evolution of the burden of active hepatitis C virus infection in England from September 2015 to September 2016: a repeated cross-sectional analysis</a><div class="gs_gray">L Lacoin, M Hurst, NR Hill, J Gordon, AM Geretti, R Aspinall, L Corless, ...</div><div class="gs_gray">BMJ open 9 (8), e029066<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3977246626125360138" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:rHJHxKgnXwkC" class="gsc_a_at">The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy</a><div class="gs_gray">A Schultze, C Torti, A Cozzi-Lepri, AM Vandamme, M Zazzi, ...</div><div class="gs_gray">Aids 33 (2), 315-326<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2894283036427702328" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:EPG8bYD4jVwC" class="gsc_a_at">Viral meningitis in UK adults-a multicentre prospective observational cohort study of incidence, aetiology and sequelae</a><div class="gs_gray">FJ McGill, M Griffiths, L Bonnett, A Geretti, B Michael, N Beeching, ...</div><div class="gs_gray">Lancet Infectious Diseases<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5214766365994055427" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Br1UauaknNIC" class="gsc_a_at">Epidemiological data for hepatitis D in Africa–Authors' reply</a><div class="gs_gray">AJ Stockdale, A Beloukas, AM Geretti</div><div class="gs_gray">The Lancet Global Health 6 (1), e34<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12528480313771921667" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:CB2v5VPnA5kC" class="gsc_a_at">Point-of-care HCV RNA screening by finger-prick is technically feasible but uptake is reduced by concomitant offer of HIV testing</a><div class="gs_gray">AM Geretti, H Austin, G Villa, J Williams, P Davies, M Hopkins, A Beloukas, ...</div><div class="gs_gray">HIV MEDICINE 19, S56-S57<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17948727941930462881" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:4X0JR2_MtJMC" class="gsc_a_at">The association between detected drug resistance mutations and CD4 (+) T-cell decline in HIV-positive individuals maintained on a failing treatment regimen</a><div class="gs_gray">A Schultze, R Paredes, C Sabin, AN Phillips, D Pillay, N Mackie, ...</div><div class="gs_gray">Antiviral therapy 23 (2), 105-116<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2191215075800049960" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:PVgj2kMGcgYC" class="gsc_a_at">Human immunodeficiency virus (HIV)</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">eLS, 1-10<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15904652395027774896" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:_axFR9aDTf0C" class="gsc_a_at">More Long-term Assessment of Transient Elastography Is Needed for HIV/Hepatitis B Virus-Coinfected Patients Undergoing Treatment With Tenofovir Reply</a><div class="gs_gray">AJ Stockdale, AM Geretti</div><div class="gs_gray">Clinical Infectious Diseases 62 (1), 130-+<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2849921925540980915" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:XoXfffV-tXoC" class="gsc_a_at">Characterizing the epidemiology and interaction between HIV-1 and HBV co-infection in South Africa</a><div class="gs_gray">PC Matthews, A Beloukas, A Malik, T Ndung’u, P Goulder, AM Geretti, ...</div><div class="gs_gray">BMC Infectious Diseases 14 (2), 1-1<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16907000468834331880" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">Clinical features and epidemiology of HIV and coinfection with TB and/or viral hepatitis in a large clinic in Jeddah, Kingdom of Saudi Arabia: P46</a><div class="gs_gray">W Bajhmoum, Z Memish, B Ali, N Beeching</div><div class="gs_gray">Hiv Medicine 15<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7668550050511824104" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">Severe virologic expression of hepatitis B virus (HBV) co-infection in HIV-positive adults starting antiretroviral therapy (ART) in malawi</a><div class="gs_gray">AM Geretti, S Aoudjane, M Chaponda, A Gonzalez del Castillo, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13348262380795205836" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:fEOibwPWpKIC" class="gsc_a_at">HIV and hepatitis B virus (HBV) outcomes after switching stavudine or zidovudine to tenofovir in subjects receiving first-line antiretroviral therapy (ART) in Ghana</a><div class="gs_gray">AM Geretti, A Stockdale, L Appiah, A Beloukas, D Adinku, D Chadwick, ...</div><div class="gs_gray">ANTIVIRAL THERAPY 19, A37-A37<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6000214879132326929" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:evX43VCCuoAC" class="gsc_a_at">Occult hepatitis B/HIV co-infection in African migrants to the UK: a point prevalence study: O6</a><div class="gs_gray">D Chadwick, T Doyle, S Ellis, A Price, M Valappil, I Abbas, AM Geretti</div><div class="gs_gray">Hiv Medicine 14<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8289016596275231844" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:1DsIQWDZLl8C" class="gsc_a_at">Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multi-cohort European case-control study using centralized ultrasensitive&nbsp;…</a><div class="gs_gray">A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ...</div><div class="gs_gray">ANTIVIRAL THERAPY 18, A41-A41<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17606055685162424078" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:TlpoogIpr_IC" class="gsc_a_at">Viral Assays Used in the Diagnosis and Management of HIV infection</a><div class="gs_gray">AM Geretti, P Vitiello</div><div class="gs_gray">ABC of HIV and AIDS 40<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2775104903834733868" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">The burden of liver disease in HIV/HBV co-infected patients accessing antireroviral therapy in Ghana: The HEPIK study</a><div class="gs_gray">L Appiah, G Foster, LA Cozzi</div><div class="gs_gray">HIV Med 13, 43<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11119797562222384495" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:NDuN12AVoxsC" class="gsc_a_at">Minority HIV-1 Drug Resistance Mutations and the Risk of NNRTI-based Antiretroviral Treatment Failure: A Systematic Review and Pooled Analysis</a><div class="gs_gray">MR Jakobsen, AM Geretti, R Thiebaut, L Ostergaard</div><div class="gs_gray">JAMA 305 (13), 1327-1335<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8632120247662588252" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:olpn-zPbct0C" class="gsc_a_at">Low-level viremia below 50 copies/mL in treated HIV-infected patients predicts viral load rebound above 400 copies/mL independently of adherence levels</a><div class="gs_gray">T Doyle, P Vitiello, C Smith, V Cambiano, A Owen, A Phillips, AM Geretti</div><div class="gs_gray">HIV Med 12, 22-23<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9133586271071572699" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:wE-fMHVdjMkC" class="gsc_a_at">Browse Articles</a><div class="gs_gray">N Lee, YH Yen, CH Hung, SN Lu, JH Wang, JC Wang, CH Chen, KM Kee, ...</div><div class="gs_gray">Antiviral Therapy 16, 237-247<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9245153858925826989" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">Treatment of HIV infection</a><div class="gs_gray">AJ Rodger, N Marshall, AM Geretti, C Booth</div><div class="gs_gray">HIV/AIDS: Atlas of investigation and management, 31-60<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16409364743235548779" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Fitness contributions of the RT mutation H208Y</a><div class="gs_gray">S Malik, P Kellam, J Johnson, P Cane, AM Geretti</div><div class="gs_gray">ANTIVIRAL THERAPY 15, A164-A164<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15082136773886968721" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:VN7nJs4JPk0C" class="gsc_a_at">Evaluation of the sensitivity and specificity of population V3 sequencing tropism prediction in comparison with 454 deep sequencing</a><div class="gs_gray">C Verhofstede, I Vandenbroucke, C Booth, E Demecheleer, H Van Marck, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1350773111062228399" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ODE9OILHJdcC" class="gsc_a_at">Long-term efficacy and safety of tenofovir in HIV/HBV co-infected patients in a clinical setting: P71</a><div class="gs_gray">A Rodger, A Geretti, A Garcia, A Corr, M Haines, G Slapak, M Johnson, ...</div><div class="gs_gray">Hiv Medicine 9, 28-29<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14822064600940250617" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">Resistance testing methodologies and mechanisms of resistance</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Journal of HIV therapy 12 (4), 84-88<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9989187346684927219" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:_kc_bZDykSQC" class="gsc_a_at">Resistance to nucleoside and nucleotide reverse transcriptase inhibitors</a><div class="gs_gray">N Shulman, M Winters</div><div class="gs_gray">Reverse Transcriptase Inhibitors in HIV/AIDS Therapy, 179-207<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=925913554483791073" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:bnK-pcrLprsC" class="gsc_a_at">Mutations at reverse transcriptase (RT) codons G196, Q207, H208, R211 and L214 are associated with drug experience and specific RT mutation patterns</a><div class="gs_gray">AM Geretti, C Sabin, D Dunn, G Nebbia, UKCHIV Cohort</div><div class="gs_gray">INT MEDICAL PRESS LTD 10 (4), S104-S104<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6888063563114026125" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Relationship between HIV-1 viral subtype, disease progression and response to antiretroviral therapy</a><div class="gs_gray">P Easterbrook, M Smith, J Mullen, S O'Shea, A Geretti, S Murad, I Chrystie, ...</div><div class="gs_gray">Hiv Medicine 4 (3)<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=125038055893162965" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:F9fV5C73w3QC" class="gsc_a_at">HIV-1 infection among black Caribbeans in SE London: P17</a><div class="gs_gray">I Aggarwal, M Smith, A Geretti, I Tatt, J Parry, S Murad, P Easterbrook</div><div class="gs_gray">Hiv Medicine 4 (3)<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8234773608687449895" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">A virological perspective on resistance in highly treatment-experienced patients.</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Journal of HIV therapy 7 (4), 97-101<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13991753958237574090" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Treatment of CMV infections after allogeneic BMT with combination of half-dose ganciclovir plus foscarnet.</a><div class="gs_gray">R Pawson, J Moore, M Potter, AM Geretti, P Griffiths, HG Prentice</div><div class="gs_gray">Blood 92 (10), 282A-282A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5791669365837338751" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:IsPWOBWtZBwC" class="gsc_a_at">HIV/AIDS: Antiretroviral drugs</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Proteins 7, 9<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17125200072084306862" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:zdjWy_NXXwUC" class="gsc_a_at">Diagnostic performance evaluation of hepatitis B e antigen rapid diagnostic tests in Malawi</a><div class="gs_gray">AJ Stockdale, NM Silungwe, IT Shawa, B Kreuels, MA Gordon, AM Geretti</div><div class="gs_gray">BMC infectious diseases 21 (1), 1-10<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ghEM2AJqZyQC" class="gsc_a_at">Effectiveness of integrase strand transfer inhibitor-based regimens in HIV-infected treatment-naive individuals: results from a European multi-cohort study</a><div class="gs_gray">B Rossetti, M Fabbiani, D Di Carlo, F Incardona, A Abecasis, P Gomes, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 76 (9), 2394-2399<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:0aBXIfxlw9sC" class="gsc_a_at">A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi suggests an historic mechanism of transmission</a><div class="gs_gray">A Stockdale, B Kreuels, IT Shawa, J Meiring, D Thindwa, N Silungwe, ...</div><div class="gs_gray">JOURNAL OF HEPATOLOGY 75, S670-S671<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:eGYfIraVYiQC" class="gsc_a_at">O07. 2 The association between a diagnosis of syphilis and hepatitis B surface antigen (HBsAg) positivity in primary care</a><div class="gs_gray">A Geretti, H Austin, G Villa, F Ferreira, J Sherlock, C Smith, S de Lusignan</div><div class="gs_gray">Sexually Transmitted Infections 97 (Suppl 1), A30-A30<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:-DxkuPiZhfEC" class="gsc_a_at">Laboratory Diagnosis</a><div class="gs_gray">AM Geretti, M Atkins, E Nastouli, D Bradshaw</div><div class="gs_gray">Hepatitis C: Epidemiology, Prevention and Elimination, 71-95<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:DyXnQzXoVgIC" class="gsc_a_at">Research news in clinical context</a><div class="gs_gray">F Ceccherini-Silberstein, M Fernández-Huerta, AM Geretti</div><div class="gs_gray">Sexually Transmitted Infections 96 (7), 471-472<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:sA9dB-pw3HoC" class="gsc_a_at">Reply to:“Revisiting the estimation of hepatitis D global prevalence”</a><div class="gs_gray">AJ Stockdale, Y Hutin, AM Geretti</div><div class="gs_gray">Journal of Hepatology 73 (5), 1280-1281<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:SIv7DqKytYAC" class="gsc_a_at">P6 Factors associated with HBsAg-positive status in primary care in England: data from the Oxford-Royal College of General Practitioners Research (RCGP) and Surveillance Centre&nbsp;…</a><div class="gs_gray">G Villa, H Austin, C Smith, S de Lusignan, J Sherlock, F Ferreira, ...</div><div class="gs_gray">Gut 69 (Suppl 1), A9-A10<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:UmS_249rOGwC" class="gsc_a_at">Evaluation of hepatitis B virus (HBV) epidemiology, vaccine impact and treatment eligibility: a census-based community serological survey in Blantyre, Malawi</a><div class="gs_gray">A Stockdale, J Meiring, IT Shawa, D Thindwa, N Silungwe, M Mbewe, ...</div><div class="gs_gray">Journal of Hepatology 73, S790<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ye4kPcJQO24C" class="gsc_a_at">No user account? Register for free. Register for free.</a><div class="gs_gray">DE McGhee, NT Broskey, K Zou, GL Dohm</div><div class="gs_gray">Exercise and Sport Sciences Reviews 48 (3), 133-139<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:1tZ8xJnm2c8C" class="gsc_a_at">HIV Glasgow-Virtual, 5-8 October 2020.</a><div class="gs_gray">A Geretti, A Stockdale, S Kelly, G Villa, L Turtle, M Semple, C Sabin</div><div class="gs_gray">J Int AIDS Soc, e25616-e25616<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:YlPif8NxrbYC" class="gsc_a_at">Predictors of long-term progression to chronic kidney disease for people living with HIV in Ghana</a><div class="gs_gray">DR Chadwick, FJ Barker, C Smith, O Perditer, Y Hardy, D Owusu, G Villa, ...</div><div class="gs_gray">ANTIVIRAL THERAPY 25, A28-A29<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:qe6vwMD2xtsC" class="gsc_a_at">Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK)</a><div class="gs_gray">AM Geretti, AJ Stockdale, SH Kelly, M Cevik, S Collins, L Waters, G Villa, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:rTD5ala9j4wC" class="gsc_a_at">Drug resistance profile according to HIV-1 viral load after long-term exposure to antiretroviral treatment in the absence of routine virological monitoring: results from a&nbsp;…</a><div class="gs_gray">G Villa, A Abdullahi, D Owusu, C Smith, M Azumah, L Sayeed, H Austin, ...</div><div class="gs_gray">HIV MEDICINE 20, 172-173<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:SGW5VrABaM0C" class="gsc_a_at">PITFALLS OF HBV DNA TESTING IN PATIENTS WITH CHRONIC HEPATITIS B THAT HAVE DETECTABLE CIRCULATING HBV RNA WHILE ON ANTIVIRAL THERAPY</a><div class="gs_gray">AM Geretti, H Austin, G Villa, A Chawla</div><div class="gs_gray">HEPATOLOGY 70, 420A-421A<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:kzcSZmkxUKAC" class="gsc_a_at">DRUG RESISTANCE PROFILES OF HIV-1 POSITIVE PATIENTS EXPERIENCING VIROLOGICAL REBOUND ON RITONAVIR-BOOSTED DARUNAVIR MONOTHERAPY</a><div class="gs_gray">A Abdullahi, OM Fopoussi, A Beloukas, VF Defo, S Moudourou, ...</div><div class="gs_gray">TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE 113, S211&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:kF1pexMAQbMC" class="gsc_a_at">LIVER HEALTH IN HIV MONOINFECTED AND HIV/HBV COINFECTED INDIVIDUALS IN GHANA</a><div class="gs_gray">G Villa, R Phillips, C Smith, D Owusu, A Abdullahi, L Sayeed, H Austin, ...</div><div class="gs_gray">TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE 113, S15-S15<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:WAzi4Gm8nLoC" class="gsc_a_at">EPIDEMIOLOGY OF HEPATITIS B AND EVALUATION OF VACCINE EFFICACY IN A CENSUS-BASED COMMUNITY SEROSURVEY OF NDIRANDE TOWNSHIP IN BLANTYRE, MALAWI</a><div class="gs_gray">AJ Stockdale, I Shawa, D Everett, AM Geretti, M Gordon</div><div class="gs_gray">TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE 113, S225&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:raTqNPD5sRQC" class="gsc_a_at">Hepatitis B virus (HBV) infection and re-activation during nucleos (t) ide reverse transcriptase inhibitor (NRTI)-sparing antiretroviral therapy in a high HBV endemicity setting</a><div class="gs_gray">A Abdullahi, OM Fopoussi, J Torimiro, M Atkins, C Kouanfack, AM Geretti</div><div class="gs_gray">Open Forum Infectious Diseases<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:FiDNX6EVdGUC" class="gsc_a_at">Liver steatosis in HIV-positive patients with and without HBV coinfection accessing care in a programmatic setting in Africa</a><div class="gs_gray">G Villa, R Phillips, C Smith, D Owusu, A Abdullahi, H Austin, L Sayeed, ...</div><div class="gs_gray">Journal of Hepatology 70, E786-E786<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:pAkWuXOU-OoC" class="gsc_a_at">Molecular characterisation of HIV acquisition events in the PARTNER study</a><div class="gs_gray">A Beloukas, J Ambrose, T Karamitros, V Cambiano, T Bruun, J Lundgren, ...</div><div class="gs_gray">HIV Medicine, 14-15<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:KNjnJ3z-R6IC" class="gsc_a_at">Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos (t) ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity&nbsp;…</a><div class="gs_gray">A Abdullahi, OM Fopoussi, J Torimiro, M Atkins, C Kouanfack, AM Geretti</div><div class="gs_gray">Open forum infectious diseases 6 (4), ofz142<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">Being part of the solution</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Sexually transmitted infections 95 (2), 81-81<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:jFemdcug13IC" class="gsc_a_at">Development of a Sensitive qPCR Assay for Quantification of Integrated HIV-1 DNA in Peripheral Blood Mononuclear Cells</a><div class="gs_gray">A Ruggiero, E Malatinkova, W De Spiegelaere, J Thomas, S Rutsaert, ...</div><div class="gs_gray">Journal of Virological Methods<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:owLR8QvbtFgC" class="gsc_a_at">Results of HIV-1 drug resistance tests performed in ART-experienced patients in the UK: patterns 2008 to 2015</a><div class="gs_gray">A Tostevin, D Dunn, O Stirrup, N Mackie, D Asboe, A Pozniak, D Churchill, ...</div><div class="gs_gray">HIV MEDICINE 19, S140-S140<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Inferring the migration routes of hepatitis C virus subtype 1a lineages identifies a need for pan-European prevention strategies</a><div class="gs_gray">L Cuypers, B Vrancken, L Fabeni, VC Di Maio, V Cento, G Baele, ...</div><div class="gs_gray">Journal of Hepatology 68, S158-S159<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:w0F2JDEymm0C" class="gsc_a_at">State of the antiretroviral therapy in human immunodeficiency virus drug resistance</a><div class="gs_gray">C Boucher, MR Bobkova, AM Geretti, CC Hung, R Kaiser, AG Marcelin, ...</div><div class="gs_gray">AIDS Reviews 20 (1), 26-41<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:PYBJJbyH-FwC" class="gsc_a_at">Antiretrovirals in nanoparticle formulation to improve control of HIV replication and prevent viral escape</a><div class="gs_gray">AM Geretti, G Villa, ULNARV Grp</div><div class="gs_gray">HIV MEDICINE 19, S39-S39<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:nRpfm8aw39MC" class="gsc_a_at">Epidemiological data for hepatitis D in Africa. Author's reply (vol 6, pg e34, 2018)</a><div class="gs_gray">AJ Stockdale, A Beloukas, AM Geretti</div><div class="gs_gray">LANCET GLOBAL HEALTH 6 (2), E151-E151<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">Unravelling HCV1a whereabouts identifies a need for a pan-European prevention program</a><div class="gs_gray">L Cuypers, B Vrancken, L Fabeni, VC Di Maio, M Parczewski, V Chulanov, ...</div><div class="gs_gray">Conference on Retroviruses and Opportunistic Infections (CROI), Date: 2018&nbsp;…<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:1lhNe0rCu4AC" class="gsc_a_at">PO232 Incidence and healthcare costs of viral meningitis in adults–a multicentre prospective observational study in england</a><div class="gs_gray">F McGill, MJ Griffiths, L Bonnett, A Martin, AM Geretti, BD Michael, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 88 (Suppl 1), A73-A73<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ALROH1vI_8AC" class="gsc_a_at">PO214 Neuropsychological sequelae of viral meningitis</a><div class="gs_gray">G Adan, M Griffiths, L Bonnett, A Miller, AM Geretti, B Michael, N Beeching, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 88 (Suppl 1), A68-A68<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Risk of hepatitis B virus (HBV) infection and re-activation after discontinuation of tenofovir and/or lamivudine as part of antiretroviral therapy in a high HBV endemicity setting</a><div class="gs_gray">A Abdullahi, A Beloukas, OM Fopoussi, J Torimiro, C Kouanfack, ...</div><div class="gs_gray">HEPATOLOGY 66, 1017A-1018A<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">Timing of detection of treatment-emergent resistance during rebound viraemia</a><div class="gs_gray">N Mackie, A Beloukas, A Geretti, T Mbysa, D Bibby, S Kaye, A Phillips, ...</div><div class="gs_gray">HIV MEDICINE 18, 4-4<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:SnGPuo6Feq8C" class="gsc_a_at">Hepatitis C Virus (HCV) RNA screening and sequencing using dry plasma spots</a><div class="gs_gray">RO Phillips, AM Geretti, S King, K Adjei-Asante, LT Appiah</div><div class="gs_gray">Elsevier BV<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of multidrug-resistant tuberculosis</a><div class="gs_gray">MC Payen, S Tiberi, G Sotgiu, L D’Ambrosio, R Centis, MA Arbex, ...</div><div class="gs_gray">Age (years) 32 (34), 0.79<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:BJbdYPG6LGMC" class="gsc_a_at">Effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of multidrug resistant tuberculosis</a><div class="gs_gray">S Tiberi, G Sotgiu, L D'Ambrosio, R Centis, MA Arbex, EA Arrascue, ...</div><div class="gs_gray">European Respiratory Journal 48 (suppl 60)<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:_5tno0g5mFcC" class="gsc_a_at">Cardiovascular risk profile of HIV patients accessing routine care at a teaching hospital in Ghana</a><div class="gs_gray">LT Appiah, G Bedu-Addo, SF Sarfo, IK Owusu, D Chadwick, AM Geretti</div><div class="gs_gray">Annals of Global Health 82 (3)<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:WC9gN4BGCRcC" class="gsc_a_at">HLA-A is a predictor of hepatitis B e antigen status in HIV-positive African adults</a><div class="gs_gray">JM Carlson, A Beloukas, A Malik, P Klenerman, AM Geretti, T Ndung'u, ...</div><div class="gs_gray">Oxford University Press<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:jE2MZjpN3IcC" class="gsc_a_at">Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV co-infected individuals in Sub-Saharan Africa: results from the HEPIK cohort</a><div class="gs_gray">RO Phillips, C Smith, A Stockdale, G Villa, A Beloukas</div><div class="gs_gray">Journal of the International AIDS Society 2016,<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:gVv57TyPmFsC" class="gsc_a_at">Long-term virological outcomes of replacing zidovudine or stavudine with tenofovir in the absence of routine virological monitoring in Kumasi, Ghana</a><div class="gs_gray">RO Phillips, C Smith, A Stockdale, G Villa, A Beloukas</div><div class="gs_gray">Journal of the International AIDS Society<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">Liver stiffness and virologic outcomes after introducing tenofovir as part of antiretroviral therapy in lamivudine-experienced adults with HIV and hepatitis B virus (HBV) co&nbsp;…</a><div class="gs_gray">A Stockdale, RO Phillips, FS Sarfo, LT Appiah, LJ Bonnett, D Chadwicks, ...</div><div class="gs_gray">HEPATOLOGY 64 (S1), abstract 1905-abstract 1905<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">Plasma and serum are suitable specimen types for quantitation of HCV RNA using real-time transcription mediated amplification or PCR</a><div class="gs_gray">S Hau, AM Geretti, M Hopkins</div><div class="gs_gray">Journal of Clinical Virology, S31-S32<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:YohjEiUPhakC" class="gsc_a_at">HLA contributes to immune control of hepatitis B in HIV-positive African adults</a><div class="gs_gray">P Matthews, A Beloukas, A Malik, J Carlson, P Jooste, A Ogwu, R Shapiro, ...</div><div class="gs_gray">Journal of Infection 71 (6), 685-686<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:1taIhTC69MYC" class="gsc_a_at">OPEN ACCESS OPEN ACCESS</a><div class="gs_gray">O ONLIN</div><div class="gs_gray">Journal of the International AIDS Society 18, 4<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:vbGhcppDl1QC" class="gsc_a_at">CSF: plasma HIV-1 RNA discordance&gt; 0.5 log10 is associated with raised inflammatory mediator profiles in CSF</a><div class="gs_gray">S Nightingale, B Michael, S King, A Beloukas, M Pirmohamed, AM Geretti, ...</div><div class="gs_gray">Hiv Medicine 16, 7-7<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">Comparative analytical performance of the new Aptima® HIV-1 RNA load assay with focus on low HIV-1 RNA levels: P31</a><div class="gs_gray">M Hopkins, S Hau, C Tiernan, A Papadimitropoulos, A Geretti, A Chawla</div><div class="gs_gray">Hiv Medicine 16<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:PELIpwtuRlgC" class="gsc_a_at">The burden of integrated HIV-1 DNA during suppressive ART is associated with levels of activated (HLA-DR+) CD8 T cells: P29</a><div class="gs_gray">A Ruggiero, S King, G Pollakis, A Beloukas, A Geretti, L Vandekerckhove, ...</div><div class="gs_gray">Hiv Medicine 16<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:XUvXOeBm_78C" class="gsc_a_at">Epidemiology of HBV infection in a cohort of Ugandan HIV-infected patients and rate and pattern of lamivudine-resistant HBV infection in patients receiving antiretroviral&nbsp;…</a><div class="gs_gray">G Calisti, R Muhindo, Y Boum, L Wilson, D Fink, G Foster, A Geretti, ...</div><div class="gs_gray">Hiv Medicine 15<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:vDijr-p_gm4C" class="gsc_a_at">The influence of gender on ART-induced reconstitution of CD4 cell counts and function: P98</a><div class="gs_gray">M Tsakiroglou, Y Wang, A Ruggiero, S King, A Beloukas, A Geretti</div><div class="gs_gray">Hiv Medicine 15<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:1yQoGdGgb4wC" class="gsc_a_at">Comparative performance of commercial plasma HIV-1 RNA load assays at low copy numbers: P255</a><div class="gs_gray">M Hopkins, C Tiernan, R Mullin, A Chawla, A Geretti</div><div class="gs_gray">Hiv Medicine 15<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Switching ART: the rates and reasons for changing first-line ART in a mixed urban cohort: P324</a><div class="gs_gray">R Thomson-Glover, A Wolujewicz, J Lewis, A Gupta, M Hopkins, ...</div><div class="gs_gray">Hiv Medicine 15<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:WZBGuue-350C" class="gsc_a_at">Impact of elvitegravir/cobicistat/tenofovir/emtricitabine failure on treatment options</a><div class="gs_gray">NE Mackie, D Webster, AM Geretti</div><div class="gs_gray">ANTIVIRAL THERAPY 19, A143-A143<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ipzZ9siozwsC" class="gsc_a_at">In vitro characterization of efavirenz-containing solid drug nanoparticles</a><div class="gs_gray">SC King, M Oliveira, D Moisi, B Brenner, M Giardiello, SP Rannard, ...</div><div class="gs_gray">ANTIVIRAL THERAPY 19, A126-A126<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:VLnqNzywnoUC" class="gsc_a_at">BHIVA Guidelines for the treatment of management of coinfection with HIV-1 and hepatitis viruses 2013</a><div class="gs_gray">E Wilkins, M Nelson, MD Awoyemi, DE Barnes, S Bhagani, G Brook, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">HIV-1 RNA and HIV-1 DNA persistence during long-term suppressive ART: O24</a><div class="gs_gray">AM Geretti, P Vitiello, S King, A Cozzi-Lepri, A Phillips</div><div class="gs_gray">Hiv Medicine 14<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:SdhP9T11ey4C" class="gsc_a_at">Genotypic Tropism Testing Utilisation in a UK Centre</a><div class="gs_gray">DC Friday, L Goodwin, NHM Fadzillah, A Chawla, AM Geretti</div><div class="gs_gray">Hiv Medicine 14, 66-67<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">HIV-1 DNA decline during long-term first-line NNRTI-based ART with consistent plasma HIV-1 RNA suppression below 50 copies/ml</a><div class="gs_gray">AM Geretti, A Cozzi-Lepri, P Vitiello, S King, A Owen, A Phillips</div><div class="gs_gray">ANTIVIRAL THERAPY 18, A27-A27<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:4MWp96NkSFoC" class="gsc_a_at">Psychological and physical symptoms and sexual behaviour among HIV-diagnosed men who have sex with men (MSM) in the UK</a><div class="gs_gray">F Lampe, A Speakman, L Sherr, A Phillips, S Collins, R Gilson, ...</div><div class="gs_gray">HIV medicine 14, 2-2<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:N5tVd3kTz84C" class="gsc_a_at">S1 High Levels of Latent TB Infection, Blood Borne Viruses and Unmet Need Among Hard to Reach Groups in London: The TB Reach Study</a><div class="gs_gray">S Yates, S Hemming, L Possas, G Fernando, V Gant, E Garber, AM Geretti, ...</div><div class="gs_gray">Thorax 67 (Suppl 2), A4-A4<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:L1USKYWJimsC" class="gsc_a_at">AUTHOR INDEX: Journal of the International AIDS Society</a><div class="gs_gray">M Cohen, C Perno, W El‐Sadr, JM Molina, M Saag, J Lundgren, ...</div><div class="gs_gray">Journal of the International AIDS Society 15, 18447<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:-jrNzM816MMC" class="gsc_a_at">Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in Ghana</a><div class="gs_gray">D Chadwick, A Stanley, S Sarfo, L Appiah, M Ankcorn, G Foster, ...</div><div class="gs_gray">AIDS 26, 000-000<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">Front &amp; Back Matter</a><div class="gs_gray">L Gürtler, J Eberle, S Sierra, H Walter, MW Tang, TF Liu, RW Shafer, ...</div><div class="gs_gray">Intervirology 55 (2)<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:AHdEip9mkN0C" class="gsc_a_at">Author and Subject Index Vol. 55, No. 2, 2012</a><div class="gs_gray">L Gürtler, J Eberle, S Sierra, H Walter, MW Tang, TF Liu, RW Shafer, ...</div><div class="gs_gray">Intervirology 55 (2), 184-184<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:KUbvn5osdkgC" class="gsc_a_at">Mutations and the Development of Anti-viral Resistance</a><div class="gs_gray">AM Geretti, G Dusheiko</div><div class="gs_gray">Chronic Hepatitis C Virus, 227-249<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:tzM49s52ZIMC" class="gsc_a_at">Brief report: Dynamics of cellular HIV-1 DNA levels over 144 weeks of darunavir/ritonavir monotherapy versus triple therapy in the MONET trial</a><div class="gs_gray">AM Geretti, JR Arribas, J Vingerhoets, G Foster, S Kinloch, A Hill, ...</div><div class="gs_gray">HIV Clinical Trials<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">Chasing the Infecting HIV-1</a><div class="gs_gray">SK Loes, AM Geretti</div><div class="gs_gray">Clinical infectious diseases 53 (12), 1280-1282<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:U_HPUtbDl20C" class="gsc_a_at">Executive Committee Members</a><div class="gs_gray">P Reiss, M Battegay, N Clumeck, F Mulcahy, J Arribas, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">Drug levels and drug resistance after interruption of NNRTI-based HAART in the SMART trial</a><div class="gs_gray">P Vitiello, A Garcia, C Booth, Z Fox, A Owen, J Johnson, A Phillips, ...</div><div class="gs_gray">Hiv Medicine 12, 4-5<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:HJSXoJQnj-YC" class="gsc_a_at">Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study</a><div class="gs_gray">C QUIROS ROLDAN, A Sonnerborg, R Kaiser, FM Codoner, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">The origin and distribution of CRF50_A1D</a><div class="gs_gray">GM Foster, JC Ambrose, TCR Conibear, E Fearnhill, A Abecasis, D Asboe, ...</div><div class="gs_gray">ANTIVIRAL THERAPY 16 (4), A151-A151<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Pathogenesis of HIV infection</a><div class="gs_gray">AM Geretti, C Booth</div><div class="gs_gray">An Atlas of Investigation and Management, 13<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:MLfJN-KU85MC" class="gsc_a_at">Significant decline in T-cell activation among patients with suppressed viraemia switching to a maraviroc-containing regimen</a><div class="gs_gray">P Vitiello, D Brudney, M Macartney, C Smith, M Johnson, AM Geretti</div><div class="gs_gray">HIV MED 12, 76-76<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:tYavs44e6CUC" class="gsc_a_at">Prolonged antiretroviral therapy initiated at seroconversion is associated with a polyfunctional HIV-1-specific T-cell profile comparable to that of long-term non-progressors&nbsp;…</a><div class="gs_gray">C Cellerai, A Harari, H Stauss, S Yerly, AM Geretti, A Carroll, T Yee, ...</div><div class="gs_gray">17th Annual Conference of the British HIV Association (BHIVA) 12<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Discontinuation of long-term ART initiated at seroconversion can be associated with prolonged high viremia and preservation of CD4 cells-abstract</a><div class="gs_gray">C Cellerai, S Yerly, ML Gougeon, MA Johnson, AM Geretti, A Carroll, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">Routine investigation and monitoring of adult HIV-1-infected individuals</a><div class="gs_gray">D Asboe, C Aitken, M Boffito, A Fakoya, AM Geretti, P Kelleher, C Orkin, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">To evaluate the impact of herpes simplex virus HSV type 2 shedding on HIV plasma viral load (VL) in HIV-positive patients diagnosed with an acute bacterial sexually transmitted&nbsp;…</a><div class="gs_gray">D Grover, L Pong, C Smith, M Johnson, A Geretti</div><div class="gs_gray">Hiv Medicine 11, 40-41<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">Patterns of HIV testing at an urban teaching hospital between 2004–7: P285</a><div class="gs_gray">S Madge, C Smith, A Evans, G Clewley, M Johnson, A Geretti</div><div class="gs_gray">Hiv Medicine 11<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:OP4eGU-M3BUC" class="gsc_a_at">Detecting hepatitis B coinfection in HIV-positive cohorts in Africa: the role of rapid and simple surface antigen screening assays: PE13. 1/9</a><div class="gs_gray">D Chadwick, F Sarfo, M Patel, A Garcia, W Labbett, R Phillips, A Geretti</div><div class="gs_gray">Hiv Medicine 10, 171-172<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:3htObqc8RwsC" class="gsc_a_at">Low-frequency M184V mutants are commonly detected in newly diagnosed patients but their clinical significance remains uncertain: PE3. 1/6</a><div class="gs_gray">C Booth, A Kiyegga, B Shaw, A Garcia-Diaz, M Johnson, K Meztner, ...</div><div class="gs_gray">Hiv Medicine 10<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Validation of V3-loop-based genotyping by direct comparison with 454 pyrosequencing in patients eligible for maraviroc initiation: PE1. 2/6</a><div class="gs_gray">L Vandekerckhove, C Verhofstede, C Booth, H Van Marck, A Geretti, ...</div><div class="gs_gray">Hiv Medicine 10<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:HIFyuExEbWQC" class="gsc_a_at">Outcomes of first-line highly active antiretroviral therapy (HAART) among men and women in the UK CHIC study: PE10. 4/1</a><div class="gs_gray">T Barber, A Geretti, A Schwenk, J Anderson, C Sabin</div><div class="gs_gray">Hiv Medicine 10<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:hSRAE-fF4OAC" class="gsc_a_at">Aiming for the long term: focus on the individual-Panel discussion</a><div class="gs_gray">G Behrens, JM Gatell, AM Geretti, L Waters</div><div class="gs_gray">INTERNATIONAL JOURNAL OF STD &amp; AIDS 20, 18-19<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Understanding protease inhibitor resistance-aiming for the long term in treatment-experienced patients</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">International journal of STD &amp; AIDS 20 (2_suppl), 12-17<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:OcBU2YAGkTUC" class="gsc_a_at">Clinical and virological correlates of HIV-1 central nervous system disease: P1268</a><div class="gs_gray">E Wey, A Geretti</div><div class="gs_gray">Clinical Microbiology &amp; Infection 15 (4)<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">High-risk sexual behaviour and HIV-1 superinfection: an indication for early initiation of antiretroviral therapy?: P150</a><div class="gs_gray">T Doyle, A Garcia-Diaz, C Booth, H Dreja, A McKnight, M Johnson, ...</div><div class="gs_gray">Hiv Medicine 10, 54-55<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Low-frequency mutations strengthen the impact of transmitted drug resistance (TDR) on virological responses to first-line efavirenz-or nevirapine-based antiretroviral therapy: O20</a><div class="gs_gray">A Strang, J Johnson, Z Fox, C Booth, A Phillips, J Li, W Heneine, A Geretti</div><div class="gs_gray">Hiv Medicine 10, 6-7<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:JQOojiI6XY0C" class="gsc_a_at">Comparative evaluation of the performance of the Cavidi ExaVir Load Assay for the measurement of B and non-B HIV-1 RNA load in plasma: P92</a><div class="gs_gray">G Foster, A Garcia-Diaz, W Labbett, G Clewley, M Johnson, A Geretti</div><div class="gs_gray">Hiv Medicine 10, 37-38<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Tweelingen: de mythe voorbij</a><div class="gs_gray">I Delbaere</div><div class="gs_gray">TIJDSCHRIFT VOOR VROEDVROUWEN 15 (4), 205-208<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:hMsQuOkrut0C" class="gsc_a_at">Hepatitis B virus genotypes and resistance in HIV-HBV coinfection</a><div class="gs_gray">A Garcia-Diaz, J Ainsworth, J Anderson, Y Gillece, S Johnston, N Mackie, ...</div><div class="gs_gray">ANTIVIRAL THERAPY 14 (4), A66-A66<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Detection of clinically relevant antiretroviral drug resistance mutations among treated patients undergoing testing at low levels of viremia</a><div class="gs_gray">AM Geretti, AN Phillips, S Kaye, C Booth, NE Mackie, ...</div><div class="gs_gray">INT MEDICAL PRESS LTD 14 (4), A60-A60<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Genotypic antiretroviral drug resistance testing at low plasma HIV-1 RNA loads in the UK: P96</a><div class="gs_gray">P Cane, S Kaye, E Smit, P Tilston, S Kirk, J Shepherd, M Hopkins, ...</div><div class="gs_gray">Hiv Medicine 9<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:OR75R8vi5nAC" class="gsc_a_at">Trends in transmitted antiretroviral resistance in London: P105</a><div class="gs_gray">G Nebbia, C Booth, A Garcia-Diaz, C Smith, S Chaitor, M Johnson, ...</div><div class="gs_gray">Hiv Medicine 9<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:cWzG1nlazyYC" class="gsc_a_at">Does point-of-care HIV testing improve testing and diagnosis in a hospital-based voluntary testing clinic?: O3</a><div class="gs_gray">G Nebbia, A Evans, M Chaytor, U Nandakumar, T Fernandez, G Clewley, ...</div><div class="gs_gray">Hiv Medicine 9<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Effect of HIV-1 subtype on virological and immunological responses to first-line HAART: O10</a><div class="gs_gray">L Harrison, A Geretti, H Green, D Dunn, E Fearnhill</div><div class="gs_gray">Hiv Medicine 9<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">The impact of resistance testing in ARV-naïve patients: does it guide optimal therapy selection and improve long-term outcomes? O8</a><div class="gs_gray">L Bansi, A Geretti, D Dunn, C Sabin</div><div class="gs_gray">Hiv Medicine 9<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:URolC5Kub84C" class="gsc_a_at">Optimal use of maraviroc in clinical practice</a><div class="gs_gray">AM Geretti, CF Perno, V Soriano</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Aul-kAQHnToC" class="gsc_a_at">A survey of vaccination history and immune status in HIV-infected persons: 012</a><div class="gs_gray">J Molton, K Stonebanks, G Nebbia, I Cropley, M Youle, M Johnson, ...</div><div class="gs_gray">Hiv Medicine 8<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:4vMrXwiscB8C" class="gsc_a_at">The prevalence of antiretroviral drug resistance in patients with detectable viraemia while on first-or subsequent-line boosted protease inhibitor-based HAART: P124</a><div class="gs_gray">C Booth, A Garcia-Diaz, M Johnson, A Geretti</div><div class="gs_gray">Hiv Medicine 8<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">HAART-Induced Reconstitution of Herpes Simplex Virus-specific IFN-γ CD4 T Cell Response Is Highly Correlated to CD4 Cell Count Gain</a><div class="gs_gray">M Ramaswamy, A Waters, E Hainsworth, C Smith, G Hardy, M Johnson, ...</div><div class="gs_gray">Journal of Infection 54 (3), e197<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">MAJOR ARTICLES AND BRIEF REPORTS-HIV/AIDS-Reconstitution of Herpes Simplex Virus-Specific T Cell Immunity in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy</a><div class="gs_gray">M Ramaswamy, A Waters, C Smith, E Hainsworth, G Hardy, M Johnson, ...</div><div class="gs_gray">Journal of Infectious Diseases 195 (3), 410<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">Rega v7. 0: an upgraded genotypic drug resistance interpretation system for HIV-1 and HIV-2 infected patients</a><div class="gs_gray">K Van Laethem, P Gomes, K Deforche, AM Geretti, R Camacho, ...</div><div class="gs_gray">European HIV Drug Resistance Workshop: From Basic Science to Clinical&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:LhH-TYMQEocC" class="gsc_a_at">The reproducibility and clinical significance of HIV viral-load blips in patients on stable first-line HAART: 06</a><div class="gs_gray">G Nebbia, C Booth, C Smith, A Garcia-Diaz, A Phillips, M Johnson, ...</div><div class="gs_gray">Hiv Medicine 7<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Point-of care testing for HIV antibody as a new model of care: 030</a><div class="gs_gray">A Chawla, G Clewley, A Evans, T Fernandez, C Donnelly, U Nandakumar, ...</div><div class="gs_gray">Hiv Medicine 7<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:fFSKOagxvKUC" class="gsc_a_at">Identifying early HIV infection: comparison of a guanidine-based HIV IgG avidity assay with the detuned EIA assay (STARHS) P70</a><div class="gs_gray">A Chawla, M Gary, C Donnelly, C Booth, M Johnson, A Geretti</div><div class="gs_gray">Hiv Medicine 7<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Occult hepatitis B in HIV-infected persons: prevalence, predictive factors and kinetics in response to HAART P45</a><div class="gs_gray">A Garcia, G Nebbia, U Ayliffe, C Smith, S Dervisevic, M Johnson, R Gilson, ...</div><div class="gs_gray">Hiv Medicine 7<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:QyXJ3EUuO1IC" class="gsc_a_at">The significance of subtype-related genetic variability: controversies and unanswered questions--Antiretroviral Resistance in Clinical Practice</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Mediscript<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">Understanding the statistical analysis of resistance data</a><div class="gs_gray">A Cozzi-Lepri</div><div class="gs_gray">Antiretroviral Resistance in Clinical Practice<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Real-time PCR based hepatitis and retrovirus assays in laboratory routine use: insights from a European user</a><div class="gs_gray">AM Geretti, A Garcia-Diaz, CL Booth, W Labett, N McAllister, GS Clewley</div><div class="gs_gray">Journal of Clinical Virology, S6<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">The prevalence of antiretroviral drug resistance in patients with low-level detectable viraemia while on HAART</a><div class="gs_gray">CL Booth, A Garcia-Diaz, G Nebbia, M Youle, M Johnson, AM Geretti</div><div class="gs_gray">ANTIVIRAL THERAPY 11 (5), S130-S130<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:t6usbXjVLHcC" class="gsc_a_at">The H208Y mutations in reverse transcriptase is significantly associated with NRTI-exposure, M184V and TAM (1) mutation pathways</a><div class="gs_gray">AM Geretti, C Sabin, D Dunn</div><div class="gs_gray">ANTIVIRAL THERAPY 11 (5), S158-S158<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">Sexually Transmitted Infections</a><div class="gs_gray">D Goldmeier, A Kocsis, M Wasserman, N Low, DJ Coetzee, ...</div><div class="gs_gray">Sex Transm Infect 81 (4)<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">HIV-1 antibody avidity testing to identify recent HIV seroconverters: 042</a><div class="gs_gray">A Chawla, M Mirfenderesk, C Donnelly, M Raza, M Johnson, A Geretti</div><div class="gs_gray">Hiv Medicine 6<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:wvYxNZNCP7wC" class="gsc_a_at">Efficacy, tolerability and durability of second-line protease inhibitor (Pl)-based therapy following failure of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI&nbsp;…</a><div class="gs_gray">K Aderogba, J Schultz, R Kulasegaram, C Taylor, C Mazhude, T Newell, ...</div><div class="gs_gray">Hiv Medicine 5, 17-18<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:DrR-2ekChdkC" class="gsc_a_at">Increased prevalence of reverse transcriptase (RT) mutation Q207D/E in lamivudine (3TC)-experienced versus treatment-naive patients suggests a role in nucleoside reverse&nbsp;…</a><div class="gs_gray">G Nebbia, F Mattes, M Smith, A Geretti</div><div class="gs_gray">Hiv Medicine 5<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:sNmaIFBj_lkC" class="gsc_a_at">Prevalence and impact of adenovirus viraemia in adult stem-cell transplant recipients treated with Campath-1H</a><div class="gs_gray">A Geretti, E Nieto, S Ramalingam, A Ho, M Smith, G Mufti, S Devereux, ...</div><div class="gs_gray">Clinical Microbiology &amp; Infection Supplement 10, 83-84<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:umqufdRvDiIC" class="gsc_a_at">Prevalance and impact of human meta pneumo virus among children and immunocompromised patients</a><div class="gs_gray">M Raza, A Chawla, E Hainsworth, M Potter, W Labbett, P Griffiths, ...</div><div class="gs_gray">Clinical Microbiology &amp; Infection Supplement 10<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:e_rmSamDkqQC" class="gsc_a_at">MAJOR ARTICLES AND BRIEF REPORTS-VIRUSES-A Randomized, Controlled Trial Comparing Ganciclovir to Ganciclovir Plus Foscarnet (Each at Half Dose) for Preemptive Therapy of&nbsp;…</a><div class="gs_gray">FM Mattes, EG Hainsworth, AM Geretti, G Nebbia, G Prentice, M Potter, ...</div><div class="gs_gray">Journal of Infectious Diseases 189 (8), 1355-1361<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Brainstem encephalitis due to primary herpes simplex virus 2 infection in a young woman</a><div class="gs_gray">JW Tang, LJ Ward, NWS Davies, AM Geretti, RS Howard, NP Hisch, ...</div><div class="gs_gray">JOURNAL OF CLINICAL VIROLOGY 28, S59-S59<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:yqoGN6RLRZoC" class="gsc_a_at">Prevalence of hepatitis C (HCV) in an ethnically diverse HIV infected cohort in South London: P46</a><div class="gs_gray">A Mohsen, A Geretti, S Murad, P Easterbrook</div><div class="gs_gray">Hiv Medicine 4 (3)<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:HeT0ZceujKMC" class="gsc_a_at">The impact of NRTI resistance mutations on responses to tenofovir as part of salvage therapy in an ethnically diverse population of drug-experienced patients in South London: P1</a><div class="gs_gray">C McDonald, R Kulasegaram, M Smith, S Kegg, C Taylor, P Easterbrook, ...</div><div class="gs_gray">Hiv Medicine 4 (3)<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:bKqednn6t2AC" class="gsc_a_at">Impact of archived NRTI resistance mutations on maintenance of virological control after switching from stavudine to tenofovir with an undetectable viral load: 012</a><div class="gs_gray">C McDonald, S Kegg, R Kulasegaram, M Smith, C Taylor, P Easterbrook, ...</div><div class="gs_gray">Hiv Medicine 4 (3)<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:tuHXwOkdijsC" class="gsc_a_at">The expanding role of common respiratory viruses in human disease</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">Journal of medical microbiology 52 (6), 443-445<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:HtS1dXgVpQUC" class="gsc_a_at">Gender, ethnicity, and risk group influence the rates of HSV-2 seroprevalence and seroincidence in HIV-infected patients</a><div class="gs_gray">A Geretti, M Ramaswamy, C Taylor, M Zuckerman, D Brown, M Smith</div><div class="gs_gray">International Journal of Std &amp; Aids 13, 23-24<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:5awf1xo2G04C" class="gsc_a_at">Prevalence and patterns of resistance to failing combination therapy with nevirapine in patients infected with non-B HIV-1 subtypes</a><div class="gs_gray">AM Geretti, M Smith, M Donati, M Zuckerman, P Easterbrook</div><div class="gs_gray">AIDS 14, S121-S121<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:HGTzPopzzJcC" class="gsc_a_at">P21 Prevalence of antiretroviral resistance mutations in treatment‐naive HIV‐1‐infected patients in South London</a><div class="gs_gray">A Geretti, M Smith, M Donati, P Easterbrook, M Zuckerman</div><div class="gs_gray">HIV Medicine 1 (3), 179-179<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Prevalence of non-B subtypes and antiretroviral resistance mutations in treatment-naive patients recently infected with HIV-1 in south London</a><div class="gs_gray">AM Geretti</div><div class="gs_gray">ANTIVIRAL THERAPY 5, 153-164<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:uWiczbcajpAC" class="gsc_a_at">Combination of ganciclovir plus foscarnet for CMV pre-emptive therapy in allogeneic BMT</a><div class="gs_gray">A Geretti</div><div class="gs_gray">Journal of Clinical Virology 12 (2), 176<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">Evaluation of cobas amplicor CMV monitor for the detection and quantification of cytomegalovirus</a><div class="gs_gray">BZ Wirgart</div><div class="gs_gray">Journal of Clinical Virology 12 (2), 176<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:foquWX3nUaYC" class="gsc_a_at">Combined foscarnet and ganciclovir at half doses for the pre-emptive treatment of CMV infection: A pilot study.</a><div class="gs_gray">R Pawson, M Potter, AM Geretti, P Griffiths, HG Prentice</div><div class="gs_gray">BRIT J HAEMATOL 105, 59-59<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Role of cytotoxic T lymphocyte responses in the control of primate immunodeficiency viruses</a><div class="gs_gray">AM Geretti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:M7yex6snE4oC" class="gsc_a_at">HIV-1 REV and TAT specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to aids</a><div class="gs_gray">CA van Baalen, O Pontesilli, RC Huisman, AM Geretti, MR Klein, ...</div><div class="gs_gray">Immunology Letters 1 (56), 31<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:uLbwQdceFCQC" class="gsc_a_at">Immunological parameters in patients with frequently recurring genital herpes and response to treatment with a combination of acyclovir and interferon‐β</a><div class="gs_gray">G Castello, V Ruocco, AM Geretti, E Celentano, M Napolitano, F Rossano, ...</div><div class="gs_gray">Journal of the European Academy of Dermatology and Venereology 1 (3), 225-231<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:X9ykpCP0fEIC" class="gsc_a_at">Pause for thought on the missing millions affected by hepatitis B: Are we doing enough? World Hepatitis Day–28th July 2019</a><div class="gs_gray">PC Matthews, M Lemoine, AM Geretti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:jSAVyFp_754C" class="gsc_a_at">Developed by the IUSTI-Europe Guideline Editorial Board</a><div class="gs_gray">R Patel, OJ Kennedy, E Clarke, A Geretti, A Nilsen, S Lautenschlager, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:-7ulzOJl1JYC" class="gsc_a_at">Editorial introductions vii Editorial introductions. HIV infection and AIDS</a><div class="gs_gray">M Fisher, L Slutsker, BJ Marston, KP Klugman, SA Madhi, C Feldman, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">Role of the co-inhibitory receptor CTLA-4 on apoptosis-prone CD8 T cells in persistent HBV infection</a><div class="gs_gray">A Schurich, P Khanna, AR Lopes, KJ Han, D Peppa, L Micco, G Nebbia, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Further reading Tools and practical guidance to support HIV indicator condition-guided testing</a><div class="gs_gray">D Gökengin, AM Geretti, J Begovac</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Characterising the Epidemiology and Interaction between HIV-1 and HBV in South Africa</a><div class="gs_gray">P Goulder, AM Geretti, P Klenerman</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:BzfGm06jWhQC" class="gsc_a_at">10. CO-RECEPTOR ANTAGONISTS, TROPISM ASSAYS AND RESISTANCE</a><div class="gs_gray">AM Geretti, R Paredes</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:43bX7VzcjpAC" class="gsc_a_at">Correction to Lancet Glob Health 2018; 6: e34</a><div class="gs_gray">AJ Stockdale, A Beloukas, AM Geretti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:IUKN3-7HHlwC" class="gsc_a_at">10. PHARMACOGENETICS OF ANTIRETROVIRAL AGENTS</a><div class="gs_gray">M Rotger, A Telenti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">A. Chawla, G. Murphy, C. Donnelly, CL Booth, M.</a><div class="gs_gray">JV Johnson, A Phillips, AM Geretti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Eastick, K. $13 (022), $20 (P27), $41 (Pl 18) Egnerov~, A. $22 (P37) Ehl, S. $17 (P16)</a><div class="gs_gray">H Einsele, MA El Bassuoni, GD Eliopoulos, B Ellero, E Ellidokuz, G Elliott, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Effect of HIV-1 subtype on virological and immunological response to first-line HAART</a><div class="gs_gray">AM Geretti, L Harrison, H Green, D Dunn</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">HIV transmission, the law and the work of the clinical team, 2010.</a><div class="gs_gray">M Poulton, J Anderson, Y Azad, J Chalmers, AM Geretti, M Nelson, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:-FonjvnnhkoC" class="gsc_a_at">HSV-2 Seroprevalence and Seroincidence in an Ethnically Diverse Cohort of HIV-1 Infected Persons</a><div class="gs_gray">M Ramaswamy, C Sabin, C McDonald, M Smith, C Taylor, AM Geretti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">HIV Transmission, the Law and the Work of the Clinical Team, January 2013.</a><div class="gs_gray">M Poulton, J Anderson, Y Azad, J Chalmers, AM Geretti, M Nelson, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=knKf83IAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=knKf83IAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Draft: 2010 European guideline for the management of genital herpes</a><div class="gs_gray">R Patel, S Alderson, A Geretti, E Foley, S Lautenschlager, J Green, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–442</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>